Data / Research funding / Florida / University of Miami School of Medicine
University of Miami School of Medicine: 526 NIH awards ($857.6M) and 2 NSF awards ($258.2K), fiscal years 2021 to 2026
University of Miami School of Medicine in Coral Gables, FL is funded under 526 NIH awards ($857.6M) and 2 NSF awards ($258.2K) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- F8THLJQSAF93
- State
- Florida
Awards
The 500 largest of 528 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP) | NIH | National Institute on Aging | 2022 to 2025 | $35,910,792 | July 1, 2022 | June 30, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| SouthEast Enrollment Center (SEEC) | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $28,782,758 | July 20, 2018 | June 30, 2024 | ZUCHNER, STEPHAN | reporter.nih.gov |
| The Florida Node Alliance of the National Drug Abuse Clinical Trials Network (CTN-121) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $26,301,696 | March 1, 2025 | February 29, 2028 | SZAPOCZNIK, JOSE | reporter.nih.gov |
| The Origins of Alzheimer Disease in African Americans | NIH | National Institute on Aging | 2022 to 2025 | $20,889,453 | September 15, 2022 | June 30, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Additional Sequencing for the Alzheimer Disease Sequencing Project (ADSP) the Follow-Up Study (FUS), The Diverse Population Initiative | NIH | National Institute on Aging | 2022 to 2024 | $20,575,729 | September 1, 2022 | August 31, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Additional Sequencing for the Alzheimer's Disease Sequencing Project (ADSP) | NIH | National Institute on Aging | 2021 to 2024 | $17,661,924 | July 1, 2020 | June 30, 2026 | VANCE, JEFFERY MARVIN | reporter.nih.gov |
| Multicultural Community Dementia Screening | NIH | National Institute on Aging | 2021 to 2025 | $13,797,203 | May 1, 2021 | January 31, 2027 | GALVIN, JAMES E | reporter.nih.gov |
| The Sylvester Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $13,016,151 | July 10, 2019 | June 30, 2029 | NIMER, STEPHEN D. | reporter.nih.gov |
| MACS/WIHS -CCS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,990,830 | April 1, 2019 | September 30, 2026 | ALCAIDE, MARIA LUISA | reporter.nih.gov |
| Miami Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $11,973,000 | August 18, 2023 | June 30, 2030 | CARRASQUILLO, OLVEEN | reporter.nih.gov |
| Sleep in Neurocognitive Aging and Alzheimers Research (SANAR) | NIH | National Institute on Aging | 2021 to 2025 | $11,494,462 | February 1, 2021 | January 31, 2027 | RAMOS, ALBERTO RAFAEL | reporter.nih.gov |
| Genomic Characterization of Alzheimer Disease Risk in Admixed Populations with Native American and Southern European Genetic Ancestry | NIH | National Institute on Aging | 2021 to 2025 | $11,411,820 | February 1, 2021 | January 31, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Women HIV Cohort Study: HIV infection and treatment among women of reproductive age | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $11,285,317 | September 27, 2019 | August 31, 2025 | ALCAIDE, MARIA LUISA | reporter.nih.gov |
| Pre-Symptomatic Familial ALS (Pre-fALS) Study: From Prodrome and Biomarkers to ALS/FTD Prevention | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $11,282,768 | September 15, 2018 | July 31, 2029 | BENATAR, MICHAEL | reporter.nih.gov |
| Miami Center for AIDS Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,391,980 | November 1, 2006 | May 31, 2027 | CHAKRABORTY, RANA | reporter.nih.gov |
| Characterizing the Genetic Risk for Alzheimer Disease in African and Admixed African-American Ancestries | NIH | National Institute on Aging | 2024 to 2025 | $8,032,655 | September 30, 2024 | August 31, 2029 | GRISWOLD, ANTHONY JOHN | reporter.nih.gov |
| Study of Treatment And Reproductive outcomes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $7,788,128 | September 12, 2025 | August 31, 2030 | ALCAIDE, MARIA LUISA | reporter.nih.gov |
| THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITE(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, STORE, CURATE, PRESERVE, AND | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,530,975 | May 1, 2025 | October 31, 2025 | SCOTT, WILLIAM | reporter.nih.gov |
| Miami Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $7,125,723 | June 28, 2018 | October 17, 2023 | CARRASQUILLO, OLVEEN | reporter.nih.gov |
| Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,908,458 | July 15, 2021 | June 30, 2027 | VANCE, JEFFERY MARVIN | reporter.nih.gov |
| Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,609,782 | September 30, 2014 | August 31, 2030 | BENATAR, MICHAEL | reporter.nih.gov |
| Southeast Enrollment Center Consortium 2 (SEEC-2) | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $6,360,000 | July 1, 2024 | June 30, 2026 | ZUCHNER, STEPHAN | reporter.nih.gov |
| Disruption of Transcription Networks in Esophageal Adenocarcinoma Tumorigenesis | NIH | National Cancer Institute | 2022 to 2025 | $6,101,526 | July 8, 2022 | June 30, 2027 | EL-RIFAI, WAEL | reporter.nih.gov |
| MorPhiC Data Resource and Administrative Coordinating Center | NIH | National Human Genome Research Institute | 2022 to 2025 | $5,628,572 | September 22, 2022 | June 30, 2027 | SCHURER, STEPHAN C | reporter.nih.gov |
| Reducing Disparities in Dementia and VCID Outcomes in a Multicultural Rural Population | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $5,484,212 | March 6, 2020 | March 21, 2025 | GALVIN, JAMES E | reporter.nih.gov |
| Novel retinal higher-order capillary hemodynamics imaging for detecting cerebral small vessel disease | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,719,171 | September 15, 2024 | September 14, 2027 | WANG, JIANHUA | reporter.nih.gov |
| Mitochondrial Biogenesis in Health and Disease | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,653,174 | June 1, 2016 | May 31, 2027 | BARRIENTOS, ANTONI | reporter.nih.gov |
| Whole Genome Sequencing in Ethnically Diverse Cohorts for the ADSP Follow-Up Study (FUS) | NIH | National Institute on Aging | 2021 | $4,626,374 | September 30, 2017 | August 31, 2024 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Innovative Deep Phenotyping of African Americans at Risk for Alzheimers disease | NIH | National Institute on Aging | 2023 to 2025 | $4,456,098 | June 1, 2023 | February 29, 2028 | LOEWENSTEIN, DAVID | reporter.nih.gov |
| Immune Dysfunction in HIV+ Opioid Users | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,823,539 | April 15, 2020 | January 31, 2027 | PAHWA, SAVITA | reporter.nih.gov |
| Randomized Phase II Trial of Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer (FastER) | NIH | National Cancer Institute | 2023 to 2025 | $3,777,161 | September 20, 2023 | August 31, 2028 | CRANE, TRACY E | reporter.nih.gov |
| Targeting Cell-Type Specific Disease Phenotypes to Promote CNS Repair | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $3,654,519 | August 1, 2023 | April 30, 2028 | LEE, JAE K | reporter.nih.gov |
| Maximizing Child Health and Learning Potential:How to Promote A School Culture of Safety in the era of COVID-19 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $3,601,342 | June 30, 2021 | November 30, 2024 | GWYNN, LISA A. | reporter.nih.gov |
| Dissecting the Genomic Etiology of non-Mendelian Early-Onset Alzheimer Disease and Related Phenotypes | NIH | National Institute on Aging | 2021 to 2023 | $3,509,847 | August 15, 2019 | April 30, 2026 | BEECHAM, GARY WAYNE | reporter.nih.gov |
| Cardiac Imaging of Neuro-Embolic Mechanisms in Atriopathies causing Stroke (CINEMAS) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,473,396 | May 1, 2024 | April 30, 2029 | GOLDBERGER, JEFFREY J | reporter.nih.gov |
| Oncogenic mechanisms, molecular stratification and therapeutic targets of brain tumors | NIH | National Cancer Institute | 2022 to 2025 | $3,447,832 | September 24, 2021 | August 31, 2028 | IAVARONE, ANTONIO | reporter.nih.gov |
| A Collaborative Search for New Genes for Non-Syndromic Deafness | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,253,367 | June 1, 2010 | May 31, 2027 | TEKIN, MUSTAFA | reporter.nih.gov |
| Deep Phenotypic Characterization of Prodromal Dementia with Lewy Bodies | NIH | National Institute on Aging | 2022 | $3,171,435 | September 30, 2022 | August 31, 2025 | GALVIN, JAMES E | reporter.nih.gov |
| Medical Scientist Training Program | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $3,153,918 | July 1, 2022 | June 30, 2027 | LIEBL, DANIEL JON | reporter.nih.gov |
| Crosstalk Between Lipid Droplets and Other Organelles in Podocytes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,102,617 | September 5, 2025 | September 4, 2029 | FORNONI, ALESSIA | reporter.nih.gov |
| UM Calabresi Clinical Oncology Research Career Development Award | NIH | National Cancer Institute | 2021 to 2025 | $3,093,598 | June 29, 2018 | August 31, 2028 | POLLACK, ALAN | reporter.nih.gov |
| THE HUMAN BRAINOME III: EQTL REGULATION BY NATURAL ANTISENSE RNA IN ALZHEIMER S DISEASE | NIH | National Institute on Aging | 2021 to 2024 | $3,041,587 | September 15, 2020 | May 31, 2026 | MYERS, AMANDA J | reporter.nih.gov |
| (PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis | NIH | National Cancer Institute | 2021 to 2025 | $2,993,160 | April 8, 2021 | March 31, 2027 | SHEMBADE, NOULA DATTU | reporter.nih.gov |
| reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA) | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,978,902 | September 1, 2022 | July 31, 2028 | SZAPOCZNIK, JOSE | reporter.nih.gov |
| The Origins of Alzheimer Disease in Individuals of African Ancestry | NIH | National Institute on Aging | 2021 | $2,962,078 | April 1, 2021 | August 31, 2022 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Polyunsaturated fatty acids as anti-arrhythmic agents. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,942,029 | September 15, 2016 | March 31, 2026 | BARRO-SORIA, RENE | reporter.nih.gov |
| Integrated Navigation Services for Treatment Adherence, Counseling, and Research (INSTACARE) | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,886,676 | September 26, 2022 | May 31, 2027 | KENYA, SONJIA | reporter.nih.gov |
| Tfh dysfunction in HIV and Aging | NIH | National Institute on Aging | 2021 to 2024 | $2,856,124 | September 30, 2020 | April 30, 2026 | PAHWA, SAVITA | reporter.nih.gov |
| The Importance of Abnormal Inflammasome Activation as a Risk Factor between Traumatic Brain Injury and Alzheimer’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,797,800 | September 20, 2021 | August 31, 2026 | DIETRICH, W DALTON | reporter.nih.gov |
| Mechanisms of sleep deficiency and effects on brain injury and neurocognitive functions among older blacks | NIH | National Institute on Aging | 2021 to 2024 | $2,787,985 | May 1, 2020 | February 28, 2026 | JEAN-LOUIS, GIRARDIN | reporter.nih.gov |
| Trans-omic analysis of epicardial adipose tissue in atrial fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,783,046 | February 1, 2021 | January 31, 2026 | GOLDBERGER, JEFFREY J | reporter.nih.gov |
| The Vascular Fibroblast: An Understudied Culprit In Postoperative Venous Stenosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,777,206 | September 23, 2025 | August 31, 2029 | MARTINEZ, LAISEL | reporter.nih.gov |
| Functions of gustatory afferent neuron types. | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $2,667,985 | July 10, 2020 | December 31, 2026 | ROPER, STEPHEN D. | reporter.nih.gov |
| Essential role of the cyclin-G associated kinase (GAK) in diffuse large B-cell lymphoma progression | NIH | National Cancer Institute | 2025 | $2,617,975 | August 1, 2025 | July 31, 2029 | SCHATZ, JONATHAN H | reporter.nih.gov |
| Recruitment for the efficacy trial of Tele-Harm Reduction in a federally qualified health center operated syringe services program | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,609,496 | May 1, 2021 | April 30, 2026 | TOOKES, HANSEL EMORY | reporter.nih.gov |
| Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations | NIH | National Eye Institute | 2021 to 2023 | $2,570,468 | March 1, 2019 | December 31, 2025 | PORCIATTI, VITTORIO | reporter.nih.gov |
| Determinants of insufficient sleep among blacks and effects on disparities in health outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,489,200 | May 15, 2019 | April 30, 2025 | JEAN-LOUIS, GIRARDIN | reporter.nih.gov |
| IL-2R-dependent mechanisms in regulation of Treg homeostasis and autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,459,074 | December 10, 2019 | November 30, 2025 | MALEK, THOMAS R | reporter.nih.gov |
| The Undiagnosed Diseases Network Clinical Site of Miami | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,377,484 | September 21, 2018 | July 31, 2028 | TEKIN, MUSTAFA | reporter.nih.gov |
| Development of A HTLV-1 Vaccine | NIH | National Cancer Institute | 2021 to 2024 | $2,357,214 | March 3, 2021 | February 28, 2026 | BARBER, GLEN N. | reporter.nih.gov |
| Revealing HIV-1 persistence in myeloid cell reservoirs | NIH | National Institute of Mental Health | 2021 to 2025 | $2,355,780 | June 1, 2018 | February 29, 2028 | STEVENSON, MARIO | reporter.nih.gov |
| Personalized Outreach and Multifaceted Interventions for Screening Enhancement (PROMISE) for Anal and Cervical Cancer Prevention and Treatment | NIH | National Cancer Institute | 2025 | $2,336,229 | September 5, 2025 | August 31, 2030 | ROSA-CUNHA, ISABELLA | reporter.nih.gov |
| Genome Studies in Hereditary Spastic Paraplegia- Beyond the Exome | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,321,479 | February 1, 2011 | February 28, 2027 | ZUCHNER, STEPHAN | reporter.nih.gov |
| Looking into the Heart of Cannabis and HIV | NIH | National Institute on Drug Abuse | 2022 | $2,302,500 | April 1, 2022 | March 31, 2026 | MARTINEZ, CLAUDIA | reporter.nih.gov |
| Defining brain pericytes as a novel and myeloid-derived HIV reservoir | NIH | National Institute of Mental Health | 2021 to 2025 | $2,298,385 | July 1, 2021 | April 30, 2027 | TOBOREK, MICHAL | reporter.nih.gov |
| Genomic, Epigenomic, and Transcriptomic Mechanisms of Contributing to Alzheimer's Disease Risk in Diverse Ancestral Populations | NIH | National Institute on Aging | 2021 | $2,290,195 | August 15, 2021 | July 31, 2024 | GRISWOLD, ANTHONY JOHN | reporter.nih.gov |
| Personalized OSA treatment and effects on AD biomarkers and cognition among blacks | NIH | National Institute on Aging | 2022 to 2025 | $2,289,107 | September 1, 2022 | May 31, 2028 | JEAN-LOUIS, GIRARDIN | reporter.nih.gov |
| Integrative Genomic Approaches for Understanding Sex Differences in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $2,288,388 | May 15, 2019 | February 28, 2025 | MARTIN, EDEN R. | reporter.nih.gov |
| University of Miami IBD Genetic Research Center: Understanding the Genetic Architecture of IBD in the South Florida community | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,285,492 | September 30, 2022 | June 30, 2027 | MCCAULEY, JACOB L | reporter.nih.gov |
| Molecular Functions of CDK1 in Gastric Tumorigenesis | NIH | National Cancer Institute | 2021 to 2025 | $2,274,554 | January 12, 2021 | December 31, 2026 | EL-RIFAI, WAEL | reporter.nih.gov |
| Miami Clinical and Translational Science Institute K12 Program | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $2,268,000 | September 1, 2023 | August 31, 2028 | RUNDEK, TATJANA | reporter.nih.gov |
| Role of cerebral vasculature in brain ischemia in HIV infection | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,266,377 | September 15, 2014 | July 31, 2026 | TOBOREK, MICHAL | reporter.nih.gov |
| Greenness, Cognitive Performance and Vascular Outcomes in the NOMAS Study | NIH | National Institute on Aging | 2021 | $2,264,013 | September 30, 2021 | August 31, 2024 | BROWN, SCOTT CHARLES | reporter.nih.gov |
| Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT) | NIH | National Institute of Mental Health | 2021 to 2023 | $2,257,672 | September 15, 2021 | September 2, 2023 | CARRICO, ADAM WAYNE | reporter.nih.gov |
| LatiNET, a Multilevel Social Network Model to Examine and Address SARS-CoV-2 Misinformation in Low-Income Latinx Communities. | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2024 | $2,250,728 | September 20, 2022 | April 1, 2025 | KANAMORI NISHIMURA, MARIANO JUAN | reporter.nih.gov |
| Stabilizing the Tripartite Synaptic Complex Following TBI | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,237,377 | February 1, 2017 | December 31, 2027 | LIEBL, DANIEL JON | reporter.nih.gov |
| Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,231,277 | May 3, 2023 | April 30, 2027 | TOMIC-CANIC, MARJANA | reporter.nih.gov |
| Identifying the Genetic Etiology of Neuropathology for Alzheimer Disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2023 | $2,223,810 | June 15, 2019 | March 31, 2026 | BEECHAM, GARY WAYNE | reporter.nih.gov |
| Intercepting novel functions of AURKA in gastric tumorigenesis | NIH | National Cancer Institute | 2022 to 2025 | $2,190,467 | September 1, 2022 | August 31, 2027 | EL-RIFAI, WAEL | reporter.nih.gov |
| FINISHING HIV: An EHE model for Latinos Integrating One-Stop-Shop PrEP Services, a Social Network Support Program and a National Pharmacy Chain | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,164,050 | June 23, 2022 | May 31, 2028 | KANAMORI NISHIMURA, MARIANO JUAN | reporter.nih.gov |
| Optimizing PrEP adherence in sexual minority men who use stimulants | NIH | National Institute on Drug Abuse | 2021 to 2022 | $2,152,006 | July 1, 2020 | July 3, 2023 | CARRICO, ADAM WAYNE | reporter.nih.gov |
| ÚNETE: Combining Friendship Support Networks and Targeted Messaging from Celebrity Influencers to Reduce Latinx Substance Use Disparities | NIH | National Institute on Drug Abuse | 2023 to 2024 | $2,149,000 | August 1, 2023 | June 30, 2025 | KANAMORI NISHIMURA, MARIANO JUAN | reporter.nih.gov |
| A Novel Computerized Cognitive Stress Test Designed for Clinical Trials in Early Alzheimer's: Relationship with Multimodal Imaging Biomarkers in Diverse Cultural Groups | NIH | National Institute on Aging | 2021 to 2023 | $2,133,766 | February 1, 2019 | November 30, 2024 | LOEWENSTEIN, DAVID | reporter.nih.gov |
| Development of CRISPR/Cas9-based exon-skipping strategies for the treatment of USH-associated deafness | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2024 | $2,113,099 | August 22, 2022 | June 30, 2027 | LIU, XUE Z | reporter.nih.gov |
| Super Greedy Trees | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,103,745 | June 1, 2021 | May 31, 2026 | ISHWARAN, HEMANT | reporter.nih.gov |
| SOURI (SMILE) | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $2,098,696 | June 1, 2023 | May 31, 2026 | JONES, DEBORAH LYNNE | reporter.nih.gov |
| Cerebral ischemia and exposure to recurrent hypoglycemia in diabetes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,090,461 | September 1, 2021 | June 30, 2027 | DAVE, KUNJAN R | reporter.nih.gov |
| HIV-1 and amyloid beta interactions at the blood-brain barrier | NIH | National Institute of Mental Health | 2021 to 2025 | $2,085,676 | September 20, 2005 | July 31, 2028 | TOBOREK, MICHAL | reporter.nih.gov |
| The study of Eicosanoids as Novel Inflammatory Mediators of CVD in Men and Women with HIV | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,085,504 | April 7, 2023 | March 31, 2027 | MARTINEZ, CLAUDIA | reporter.nih.gov |
| DORMIR: Determinants, Outcomes, Responses and Markers of Insufficient sleep in Rural-Urban settings | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,083,523 | September 5, 2020 | August 31, 2025 | SEIXAS, AZIZI | reporter.nih.gov |
| Defining a Role for Liver Myeloid Cells in Viral Persistence under ART | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,074,301 | July 1, 2022 | April 30, 2027 | STEVENSON, MARIO | reporter.nih.gov |
| Pathophysiological Significance of Atrial Fibrillation Electrogram Patterns | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,061,865 | July 1, 2023 | April 30, 2028 | GOLDBERGER, JEFFREY J | reporter.nih.gov |
| Post Maria Puerto Rican Families Relocated to Florida: A Multisite Study of Alcohol Misuse and Mental Health Problems | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2023 | $2,050,480 | August 14, 2019 | March 28, 2025 | BROWN, ERIC C | reporter.nih.gov |
| Health Promotion in the Prevention of Anxiety and Depression: The Happy Older Latinos are Active (HOLA Study) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2023 | $2,039,948 | May 9, 2019 | July 31, 2025 | JIMENEZ, DANIEL ENRIQUE | reporter.nih.gov |
| Application of mild therapeutic hypothermia for hearing conservation during cochlear implant surgeries | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,038,315 | January 11, 2021 | December 31, 2026 | RAJGURU, SUHRUD M. | reporter.nih.gov |
| Evaluating risk factors for cirrhosis progression and response to statin therapy among a cohort of patients with cirrhosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,035,766 | September 22, 2021 | July 31, 2027 | GOLDBERG, DAVID SETH | reporter.nih.gov |
| New computational tools for understanding and predicting AD via age-associated DNA methylation changes | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,020,719 | September 15, 2022 | August 31, 2025 | WANG, LILY | reporter.nih.gov |
| Roles of mechanotransduction in organ regeneration and fibrosis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,017,930 | July 1, 2021 | April 30, 2027 | MENG, ZHIPENG | reporter.nih.gov |
| Estimating the cost of peer specialists providing comprehensive healthcare services at a syringe services program | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,007,015 | June 1, 2023 | March 31, 2028 | TOOKES, HANSEL EMORY | reporter.nih.gov |
| Setting the Stage for Replacement of Mitochondrial Genes | NIH | National Eye Institute | 2021 to 2025 | $2,004,064 | December 1, 1994 | August 31, 2027 | MORAES, CARLOS TORRES | reporter.nih.gov |
| The role of regulator of G protein signaling Gbeta5-R7 in neuronal control of body weight | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,995,252 | January 28, 2021 | December 31, 2025 | SLEPAK, VLADLEN Z | reporter.nih.gov |
| Endothelial cell dysfunction in cerebral aneurysm pathogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,994,271 | December 1, 2021 | November 30, 2025 | STARKE, ROBERT MICHAEL | reporter.nih.gov |
| Molecular mechanisms governing the ubiquitination signaling during KSHV cell entry and tumorigenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,992,560 | July 1, 2021 | June 30, 2027 | SHEMBADE, NOULA DATTU | reporter.nih.gov |
| Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants | NIH | National Eye Institute | 2021 to 2025 | $1,990,241 | April 1, 2020 | February 28, 2030 | LEVY, ROBERT BENJAMIN | reporter.nih.gov |
| Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis | NIH | National Cancer Institute | 2021 to 2024 | $1,972,648 | May 1, 2010 | February 28, 2026 | SHEMBADE, NOULA DATTU | reporter.nih.gov |
| Developing a kinase inhibitor drug to treat spinal cord injury | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,959,367 | February 4, 2022 | January 31, 2027 | AL ALI, HASSAN | reporter.nih.gov |
| Conformal islet encapsulation for transplantation at vascularized sites to allow physiological insulin secretion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,946,597 | July 5, 2016 | February 28, 2029 | TOMEI, ALICE | reporter.nih.gov |
| A Physiologic Adaptive Radiation Therapy Pipeline for Glioblastoma by Daily Multiparametric MRI and Machine Learning | NIH | National Cancer Institute | 2022 to 2025 | $1,941,434 | March 3, 2022 | August 1, 2025 | MELLON, ERIC ALBERT | reporter.nih.gov |
| Exosomal Gasdermin D Mediated Lung to Brain Crosstalk in Preterm Brain Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,938,967 | August 5, 2020 | June 30, 2025 | WU, SHU | reporter.nih.gov |
| Relationship between methamphetamine use, viral reservoir dynamics and clinical progression in treated HIV infection | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,936,729 | June 1, 2023 | April 30, 2028 | STEVENSON, MARIO | reporter.nih.gov |
| Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,935,846 | May 15, 2018 | March 31, 2025 | BENATAR, MICHAEL | reporter.nih.gov |
| Jump Start+:COVID Support to improve resiliency and mitigate risks in childcare centers serving children from low-income ethnic minority backgrounds. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $1,929,425 | April 7, 2022 | March 31, 2026 | NATALE, RUBY ANN | reporter.nih.gov |
| Molecular Genetics on Non Syndromic Hearing Loss (NSHL) | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $1,894,008 | September 15, 2001 | July 31, 2028 | LIU, XUE Z | reporter.nih.gov |
| Genomic Studies in Charcot-Marie-Tooth Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,886,243 | September 15, 2019 | July 31, 2025 | ZUCHNER, STEPHAN | reporter.nih.gov |
| 3-Dimensional Retinal Organoid Platform for the Study of Retinoblastoma | NIH | National Cancer Institute | 2021 to 2024 | $1,863,510 | September 15, 2020 | June 30, 2025 | PELAEZ, DANIEL | reporter.nih.gov |
| The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease | NIH | National Institute on Aging | 2022 to 2025 | $1,853,399 | September 15, 2022 | May 31, 2026 | WAHLESTEDT, CLAES ROBERT | reporter.nih.gov |
| Microglia and Epigenetic Regulation in Opioid Addiction | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,842,000 | July 1, 2020 | May 31, 2025 | TUESTA, LUIS MIGUEL | reporter.nih.gov |
| Targeting Inflammasomes in Substance Abuse and HIV | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,835,835 | July 15, 2020 | May 31, 2026 | TOBOREK, MICHAL | reporter.nih.gov |
| Unraveling the Role of Langerhans Cells in Itch | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $1,826,181 | September 1, 2025 | August 31, 2028 | AKIYAMA, TASUKU | reporter.nih.gov |
| Molecular mechanisms of exocytotic vesicle fusion and release. | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,820,811 | January 1, 2021 | December 31, 2025 | LINDAU, MANFRED | reporter.nih.gov |
| Glial ion channels in glia/neurons interactions | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,811,300 | June 1, 2018 | June 30, 2028 | BIANCHI, LAURA | reporter.nih.gov |
| Elucidation of Integrator's Function | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,791,432 | August 1, 2010 | May 31, 2027 | SHIEKHATTAR, RAMIN | reporter.nih.gov |
| Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism | NIH | National Cancer Institute | 2021 to 2025 | $1,789,036 | March 5, 2021 | February 28, 2026 | WELFORD, SCOTT MICHAEL | reporter.nih.gov |
| Functional Role of O-glycosylation of HIV-1 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,784,706 | February 15, 2013 | February 28, 2026 | DESROSIERS, RONALD C | reporter.nih.gov |
| Targeting Lipid Clearance Pathways to Promote Repair after SCI | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,779,784 | September 1, 2012 | April 30, 2028 | LEE, JAE K | reporter.nih.gov |
| PrEParados: A Multi-Level Social Network Model to Increase PrEP Enrollment by Latino MSM Self-Identified as Gay, Bisexual | NIH | National Institute of Mental Health | 2021 to 2023 | $1,769,932 | December 1, 2020 | October 31, 2024 | KANAMORI NISHIMURA, MARIANO JUAN | reporter.nih.gov |
| Meaning-Centered Grief Therapy for Parents Bereaved by Cancer: A Multisite Randomized Controlled Trial | NIH | National Institute of Nursing Research | 2023 to 2025 | $1,764,765 | August 26, 2021 | May 31, 2027 | LICHTENTHAL, WENDY G. | reporter.nih.gov |
| Clinical Centers for the NINDS NeuroNEXT(Network of Excellence in Neuroscience Clinical Trials) Consortium | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,760,444 | July 1, 2018 | June 30, 2028 | BENATAR, MICHAEL | reporter.nih.gov |
| Additional Sequencing Cohorts for the Alzheimer's Disease Sequencing Project | NIH | National Institute on Aging | 2021 | $1,758,467 | September 1, 2019 | August 31, 2024 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Impaired phospholipid metabolism in glaucoma | NIH | National Eye Institute | 2021 to 2024 | $1,752,892 | March 1, 2021 | February 28, 2026 | BHATTACHARYA, SANJOY K | reporter.nih.gov |
| ISCHEMIC PRECONDITIONING: MECHANISMS OF NEUROPROTECTION | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $1,742,667 | May 1, 1997 | August 31, 2025 | PEREZ-PINZON, MIGUEL A | reporter.nih.gov |
| pH regulation of cell surface receptors | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,733,104 | August 1, 2016 | November 30, 2026 | ISOM, DANIEL | reporter.nih.gov |
| Illuminating the Druggable Genome Resource Dissemination and Outreach Center (IDG-RDOC) | NIH | National Center for Advancing Translational Sciences | 2021 to 2023 | $1,731,443 | December 1, 2017 | November 30, 2024 | SCHURER, STEPHAN C | reporter.nih.gov |
| Immune correlates of LTBI in HIV-exposed infants | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $1,724,753 | January 5, 2019 | December 31, 2025 | PAHWA, SAVITA | reporter.nih.gov |
| Vaccination against antigens induced by TAP downregulation in concurrent and future tumors | NIH | National Cancer Institute | 2021 to 2025 | $1,724,055 | August 1, 2021 | July 31, 2027 | GILBOA, ELI | reporter.nih.gov |
| MRI Imaging and Biomarkers for Early Detection of Aggressive Prostate Cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,720,463 | September 16, 2019 | August 31, 2025 | POLLACK, ALAN | reporter.nih.gov |
| The Role of Vascular Calprotectin in Arteriovenous Fistula Maturation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,713,498 | May 1, 2022 | April 30, 2027 | VAZQUEZ PADRON, ROBERTO IRENARDO | reporter.nih.gov |
| Real time risk prognostication via scalable hazard trees and forests | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,712,564 | April 1, 2023 | March 31, 2027 | ISHWARAN, HEMANT | reporter.nih.gov |
| Polyamine and Glutamate Driven Interactions in the Glioblastoma-Brain Microenvironment | NIH | National Cancer Institute | 2021 to 2025 | $1,706,819 | August 7, 2015 | January 31, 2027 | WELFORD, SCOTT MICHAEL | reporter.nih.gov |
| MECHANISMS OF NEUROPROTECTION AGAINST CARDIAC ARREST | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,701,248 | June 1, 2004 | July 31, 2026 | PEREZ-PINZON, MIGUEL A | reporter.nih.gov |
| Effects of Iron Accumulation in Intracortical Implants and Protection by Iron Chelation | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,693,784 | April 1, 2023 | March 31, 2028 | PRASAD, ABHISHEK | reporter.nih.gov |
| Altering the chromostasis and genome stability by modulating histone methylation | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,688,395 | September 2, 2022 | June 30, 2026 | MOREY, LLUIS | reporter.nih.gov |
| Optimizing Intensive Care Unit Staffing in the United States | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,685,964 | April 15, 2021 | March 31, 2027 | GERSHENGORN, HAYLEY BETH | reporter.nih.gov |
| Epigenetic modulation of amygdalar circuits that control alcohol compulsivity | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $1,682,685 | September 1, 2022 | May 31, 2027 | WAHLESTEDT, CLAES ROBERT | reporter.nih.gov |
| Program to Increase Diversity in Behavioral Medicine and Sleep Disorders Research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,646,428 | September 20, 2010 | December 31, 2028 | JEAN-LOUIS, GIRARDIN | reporter.nih.gov |
| Implementing genomic medicine in clinical care of deaf patients | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2022 | $1,640,667 | March 8, 2013 | July 31, 2023 | LIU, XUE Z | reporter.nih.gov |
| Florida Regional Coordinating Center for the NINDS Stroke Trials Network | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,638,986 | August 1, 2018 | November 30, 2028 | ROMANO, JOSE G | reporter.nih.gov |
| Role of mTORC1 signaling in type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,626,721 | April 1, 2022 | March 31, 2026 | BERNAL-MIZRACHI, ERNESTO | reporter.nih.gov |
| Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,616,145 | September 30, 2019 | June 30, 2025 | ROY, SABITA | reporter.nih.gov |
| Wide-field corneal microlayer tomography for keratoconus | NIH | National Eye Institute | 2022 to 2025 | $1,614,091 | January 1, 2022 | December 31, 2026 | RUGGERI, MARCO | reporter.nih.gov |
| Novel Mechanisms of ROS/RNS Signaling Underlying Castration-Resistant Prostate Cancer Emergence and Progression | NIH | National Cancer Institute | 2021 to 2024 | $1,598,629 | July 7, 2020 | June 30, 2026 | RAI, PRIYAMVADA | reporter.nih.gov |
| The role of type 2 inflammation in the initiation and progression of metaplastic differentiation and neoplastic transformation of gastric epithelia | NIH | National Cancer Institute | 2021 to 2024 | $1,585,931 | June 1, 2020 | May 31, 2026 | CHEN, ZHIBIN | reporter.nih.gov |
| A Multifaceted Approach to Study Tissue and Cell Type Specific Molecular Mechanisms of the Host Response to Acute/Chronic Viral Infection | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,580,127 | September 10, 2017 | July 31, 2028 | THOMAS, EMMANUEL | reporter.nih.gov |
| Role of innate immunity and the microbiome in colitis-associated dysplasia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,577,776 | September 1, 2014 | April 30, 2027 | ABREU, MARIA TERESA | reporter.nih.gov |
| Miami Center for Vision Research | NIH | National Eye Institute | 2021 to 2025 | $1,570,052 | May 1, 2004 | April 30, 2028 | HACKAM, ABIGAIL S | reporter.nih.gov |
| Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,555,079 | September 30, 2019 | July 31, 2024 | CARRICO, ADAM WAYNE | reporter.nih.gov |
| Vectored delivery of anti-HIV antibodies for mucosal protection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,548,010 | March 14, 2023 | February 28, 2027 | MARTINEZ-NAVIO, JOSE MARIA | reporter.nih.gov |
| The functional impact of pancreatic islet innervation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,545,562 | August 1, 2021 | May 31, 2025 | CAICEDO, ALEJANDRO | reporter.nih.gov |
| Polygenic Risk Moderates the Impact of Greenness on Cardiovascular Health among HCHS/SOL Hispanic/Latinos | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,533,561 | July 1, 2020 | June 30, 2024 | BROWN, SCOTT CHARLES | reporter.nih.gov |
| Developing strategies for effective debridement in patients for venous leg ulcers | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,531,119 | September 1, 2018 | November 30, 2024 | TOMIC-CANIC, MARJANA | reporter.nih.gov |
| New DNA methylation biomarkers for predicting AD and cognitive decline | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,528,074 | April 1, 2024 | March 31, 2027 | WANG, LILY | reporter.nih.gov |
| Glial KCNQ channels. | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,527,552 | May 15, 2022 | March 31, 2027 | BIANCHI, LAURA | reporter.nih.gov |
| Dependency of AML on CARM1 activity | NIH | National Cancer Institute | 2021 to 2024 | $1,525,290 | July 1, 2020 | June 30, 2026 | NIMER, STEPHEN D. | reporter.nih.gov |
| The delta cell as a key regulator of pancreatic islet biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,519,650 | June 5, 2020 | April 30, 2025 | RODRIGUEZ-DIAZ, RAYNER | reporter.nih.gov |
| Investigating the link between pericyte dysfunction and loss of glucose homeostasis in COVID-19 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,519,650 | July 15, 2022 | May 31, 2027 | ALMACA, JOANA | reporter.nih.gov |
| Disease Modifying Analgesia with CA8 Gene Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,516,241 | September 30, 2021 | September 15, 2023 | LEVITT, ROY C. | reporter.nih.gov |
| Amino acid sensing mechanisms in beta and alpha cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,503,819 | July 1, 2022 | May 31, 2027 | BERNAL-MIZRACHI, ERNESTO | reporter.nih.gov |
| Molecular mechanisms of programmed necrosis in the ischemic retina | NIH | National Eye Institute | 2021 to 2024 | $1,500,450 | September 1, 2021 | July 31, 2025 | IVANOV, DMITRY V | reporter.nih.gov |
| Using ethics, epidemiology and high-quality data to optimize the allocation of livers for transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,498,133 | April 1, 2019 | March 31, 2025 | GOLDBERG, DAVID SETH | reporter.nih.gov |
| The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection | NIH | National Cancer Institute | 2023 to 2025 | $1,497,955 | July 12, 2023 | June 30, 2028 | PUNNEN, SANOJ | reporter.nih.gov |
| Research Training in Surgical Oncology | NIH | National Cancer Institute | 2021 to 2025 | $1,497,895 | September 15, 2016 | August 31, 2026 | MERCHANT, NIPUN B. | reporter.nih.gov |
| Th17 cells as a new therapeutic target for depression | NIH | National Institute of Mental Health | 2021 to 2024 | $1,497,135 | April 1, 2015 | April 30, 2026 | BEUREL, ELEONORE | reporter.nih.gov |
| Genomic, Epigenomic, and Transcriptomic Mechanisms of Contributing to Alzheimer's Disease Risk in Diverse Ancestral Populations | NIH | National Institute on Aging | 2024 to 2025 | $1,494,418 | August 15, 2021 | July 31, 2027 | GRISWOLD, ANTHONY JOHN | reporter.nih.gov |
| Comparative Study of Haitian and Miami Cohorts of Haitian-American and Haitian Immigrant Children with Sickle Cell Disease (CSHSCD) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,492,725 | September 1, 2019 | June 30, 2025 | ALVAREZ, OFELIA AMPARO | reporter.nih.gov |
| Role of ASC in TBI-Mediated Systemic Inflammation. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,476,248 | December 1, 2019 | November 30, 2025 | KEANE, ROBERT W | reporter.nih.gov |
| Assessing Benefits and Harms of Medical Cannabis and Cannabinoid Use in Breast Cancer Patients During and After Treatments | NIH | National Cancer Institute | 2023 to 2025 | $1,471,480 | September 20, 2023 | August 31, 2029 | HU, JENNIFER J | reporter.nih.gov |
| Targeted cell delivery for treatment of non-healing wounds and gangrene | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,463,290 | May 15, 2019 | October 31, 2023 | LIU, ZHAO-JUN | reporter.nih.gov |
| Test-to-PrEP: A Randomized Hybrid Implementation/Effectiveness Trial of a Social Network Strategy to Increase Equitable Reach of HIV Testing and PrEP Information | NIH | National Institute of Mental Health | 2024 to 2025 | $1,444,144 | September 1, 2024 | June 30, 2029 | DOBLECKI-LEWIS, SUSANNE | reporter.nih.gov |
| Implications of Obstructive Sleep Apnea for Fat Metabolism | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,431,810 | January 20, 2021 | June 30, 2024 | PUNJABI, NARESH M | reporter.nih.gov |
| Defining role of FANCA in genome instability | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,431,460 | September 1, 2021 | October 31, 2024 | ZHANG, YANBIN | reporter.nih.gov |
| Smoothened as a Novel Signal Stabilization Scaffold in Doxorubicin Resistance | NIH | National Cancer Institute | 2021 to 2023 | $1,431,130 | April 3, 2019 | March 31, 2025 | LANDGRAF, RALF | reporter.nih.gov |
| Enhancing Sympathetic Outflow Control Following Spinal Cord Injury Using Targeted Plasticity Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,419,630 | March 15, 2023 | February 29, 2028 | GANZER, PATRICK D | reporter.nih.gov |
| Promoting Academic Workforce Development in Translational Behavioral and Cardio-Metabolic Research-PINNACLE | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,418,761 | February 1, 2023 | January 31, 2028 | JEAN-LOUIS, GIRARDIN | reporter.nih.gov |
| APOM deficiency contributes to renal failure in glomerular diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,415,462 | July 1, 2023 | April 30, 2027 | FORNONI, ALESSIA | reporter.nih.gov |
| The Evolution of PGD Addiction in Human Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,413,922 | December 1, 2018 | July 31, 2030 | MCDONALD, OLIVER GENE | reporter.nih.gov |
| Molecular Mechanisms of Epilepsy-Causing Mutations in IKM channels: anti-epileptic effect of Lipophilic compounds. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,409,055 | January 1, 2020 | March 31, 2025 | BARRO-SORIA, RENE | reporter.nih.gov |
| Institutional Career Development Core | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $1,406,462 | June 28, 2018 | October 31, 2023 | RUNDEK, TATJANA | reporter.nih.gov |
| Neural and Psychiatric Consequences of Cannabis Use in Adolescents | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,405,084 | September 30, 2024 | May 31, 2029 | GABBAY, VILMA | reporter.nih.gov |
| Rac guanine nucleotide exchange factors in lung cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,393,598 | July 31, 2024 | August 31, 2027 | KAZANIETZ, MARCELO G. | reporter.nih.gov |
| Comprehensive Research Experiences to Advance Training and Education (CREATE) for Future Cancer Researchers | NIH | National Cancer Institute | 2021 to 2025 | $1,380,979 | August 1, 2021 | July 31, 2026 | RAI, PRIYAMVADA | reporter.nih.gov |
| Efficacy Trial of Healthy Juntos: A Family-based Digital Lifestyle Intervention for Hispanic Adolescents and their Parents | NIH | National Cancer Institute | 2024 to 2025 | $1,365,961 | June 12, 2024 | May 31, 2029 | ST. GEORGE, SARA MIJARES | reporter.nih.gov |
| Mechanisms underlying recurrent bacterial vaginosis and HIV risk A Multidisciplinary approach | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $1,364,663 | August 20, 2018 | July 31, 2025 | ALCAIDE, MARIA LUISA | reporter.nih.gov |
| Native Alzheimer Disease Resource Center for Minority Aging Research (NAD-RCMAR) | NIH | National Institute on Aging | 2023 to 2024 | $1,355,609 | September 1, 2018 | June 30, 2025 | GALVIN, JAMES E | reporter.nih.gov |
| Mapping gustatory neuron types. | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2023 | $1,347,304 | March 1, 2019 | February 28, 2026 | CHAUDHARI, NIRUPA | reporter.nih.gov |
| Project ACCESS: Advancing Access to HIV/HCV Testing Through Transformation in Syringe Services Programs: A Cluster Randomized Trial | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,343,426 | July 1, 2024 | April 30, 2029 | BARTHOLOMEW, TYLER SCOTT | reporter.nih.gov |
| Evolution and targeting of the functional states of glioblastoma | NIH | National Cancer Institute | 2022 to 2025 | $1,339,076 | July 1, 2022 | June 30, 2027 | LASORELLA, ANNA | reporter.nih.gov |
| The Neuroimmunology of Depression in Women Living With HIV | NIH | National Institute of Mental Health | 2024 to 2025 | $1,323,825 | September 16, 2021 | June 30, 2027 | GABBAY, VILMA | reporter.nih.gov |
| Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness | NIH | National Cancer Institute | 2022 to 2025 | $1,323,242 | June 17, 2022 | May 31, 2027 | POLLACK, ALAN | reporter.nih.gov |
| Loss of insulin signaling across functional pancreas compartments as a major pathogenic mechanism underlying diabetic exocrine pancreatopathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,312,066 | January 12, 2024 | December 31, 2028 | CAICEDO, ALEJANDRO | reporter.nih.gov |
| MPZL3 as a Therapeutically Targetable Mitochondrial Regulator of Sebaceous Gland Homeostasis and Sebum Production | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,306,899 | April 15, 2022 | February 28, 2027 | WIKRAMANAYAKE, TONGYU CAO | reporter.nih.gov |
| Protein kinase C and lung carcinogenesis | NIH | National Cancer Institute | 2024 to 2025 | $1,294,603 | June 1, 2024 | May 31, 2028 | KAZANIETZ, MARCELO G. | reporter.nih.gov |
| Mechanisms of RING1B and PRC1 complexes in transcriptional activation | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,289,400 | January 1, 2022 | December 31, 2026 | MOREY, LLUIS | reporter.nih.gov |
| Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,272,742 | September 15, 2018 | August 31, 2024 | BENATAR, MICHAEL | reporter.nih.gov |
| Targeted therapy for t(8;21)+ AML | NIH | National Cancer Institute | 2021 to 2025 | $1,252,041 | September 17, 2012 | February 28, 2029 | NIMER, STEPHEN D. | reporter.nih.gov |
| Elucidating a novel molecular biomarker for castration-resistant prostate cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,245,269 | September 26, 2012 | July 31, 2028 | SHARIFI, NIMA | reporter.nih.gov |
| Amyloid-bodies and the Evolution of Malignancies | NIH | National Cancer Institute | 2023 to 2025 | $1,241,166 | August 7, 2023 | July 31, 2028 | LEE, STEPHEN | reporter.nih.gov |
| Inflammation, BBB disruption, and Reward Function in the Pathogenesis of Depression among PWH | NIH | National Institute of Mental Health | 2024 to 2025 | $1,235,378 | February 20, 2024 | June 30, 2027 | GABBAY, VILMA | reporter.nih.gov |
| Human Schwann Cell-Derived Exosome Treatment for Traumatic Brain Injury | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,227,651 | August 1, 2023 | July 31, 2027 | DIETRICH, W DALTON | reporter.nih.gov |
| Metabolic deficits and immune dysfunction in aging people living with HIV | NIH | National Institute on Aging | 2024 to 2025 | $1,226,631 | July 1, 2024 | June 30, 2029 | FRASCA, DANIELA | reporter.nih.gov |
| Dual Role of Lysyl Oxidase in Arteriovenous Fistula Failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,211,449 | September 17, 2019 | April 30, 2025 | VAZQUEZ PADRON, ROBERTO IRENARDO | reporter.nih.gov |
| Low dose IL-2 and human regulatory T cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,206,674 | November 21, 2017 | November 30, 2023 | MALEK, THOMAS R | reporter.nih.gov |
| Cellular and Molecular Consequences of Respiratory Chain Defects in Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,203,623 | May 15, 2012 | March 31, 2025 | MORAES, CARLOS TORRES | reporter.nih.gov |
| Optimizing encapsulation to treat Type 1 diabetes mellitus: the role of oxygenation, antigen shedding and innate immune response in graft success | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,199,902 | January 15, 2019 | August 31, 2025 | FRAKER, CHRISTOPHER ALAN | reporter.nih.gov |
| Understanding CTCF Boundaries Controlling Hox Gene Expression | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,186,622 | March 15, 2018 | July 31, 2029 | REINBERG, DANNY | reporter.nih.gov |
| 3/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,185,356 | August 10, 2023 | July 31, 2030 | GOLDBERG, DAVID SETH | reporter.nih.gov |
| Family Study of Carotid Atherosclerosis and Stroke Risk | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,182,122 | May 1, 2002 | March 31, 2024 | RUNDEK, TATJANA | reporter.nih.gov |
| 1-13 ApoL1 Genotypes in Kidney Donors and Long-Term Outcomes in Kidney Transplant Recipients Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,177,436 | September 25, 2017 | May 31, 2028 | FORNONI, ALESSIA | reporter.nih.gov |
| Gamma-2 Herpesviruses as Vaccine Vectors for AIDS | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,167,076 | March 15, 2005 | November 30, 2022 | DESROSIERS, RONALD C | reporter.nih.gov |
| Precision-based Assessment for the Detection of Mild Cognitive Impairment in Older Adults | NIH | National Institute on Aging | 2021 to 2022 | $1,166,256 | April 1, 2018 | January 31, 2024 | CURIEL CID, ROSIE E | reporter.nih.gov |
| Protein kinase C signaling in prostate cancer health disparities | NIH | National Cancer Institute | 2024 to 2025 | $1,159,789 | June 8, 2023 | May 31, 2028 | KAZANIETZ, MARCELO G. | reporter.nih.gov |
| Mucosal surface and skin protection by MHC class I-based immune regulation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,151,250 | November 15, 2018 | October 31, 2025 | CHEN, ZHIBIN | reporter.nih.gov |
| Redefining The Role Of Myosin Essential Light Chain In Cardiac Muscle | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,151,250 | April 5, 2020 | March 31, 2024 | SZCZESNA-CORDARY, DANUTA | reporter.nih.gov |
| Single-cell longitudinal analysis of regeneration in human pancreatic slices | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,151,250 | September 20, 2021 | August 31, 2025 | DOMINGUEZ-BENDALA, JUAN | reporter.nih.gov |
| The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,151,250 | January 1, 2023 | December 31, 2027 | DONG, CHUNMING | reporter.nih.gov |
| The Nucleolar Detention Center: A Hub of Long Noncoding RNA that Imprison Proteins during Stress | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,151,250 | April 1, 2023 | March 31, 2028 | LEE, STEPHEN | reporter.nih.gov |
| The role of XPO1 in nuclear export of RNA | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,151,250 | August 15, 2023 | July 31, 2028 | TAYLOR, JUSTIN | reporter.nih.gov |
| Validation and Implementation of an Artificial Intelligence Machine-to-Machine (M2M) Model for Glaucoma Screening | NIH | National Eye Institute | 2024 to 2025 | $1,150,086 | September 30, 2024 | July 31, 2028 | MEDEIROS, FELIPE | reporter.nih.gov |
| Inflammasome Activation and Gut-Brain Axis Dysregulation in HIV and Methamphetamine-Associated Depression | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,146,614 | March 15, 2024 | January 31, 2029 | TOBOREK, MICHAL | reporter.nih.gov |
| microRNA regulation of NMNAT-mediated Neuroprotection against Peripheral Neuropathy and Chronic Pain | NIH | National Center for Complementary & Integrative Health | 2022 to 2023 | $1,145,822 | August 16, 2019 | June 30, 2025 | ZHAI, RONG GRACE | reporter.nih.gov |
| Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,140,505 | May 24, 2022 | May 31, 2026 | VELAZQUEZ, OMAIDA C | reporter.nih.gov |
| 3D visualization and Investigation of Retinal Axon Regeneration | NIH | National Eye Institute | 2021 to 2023 | $1,139,738 | April 1, 2021 | February 29, 2024 | PARK, KEVIN KYUNG | reporter.nih.gov |
| The role of the TET-dependent DNA demethylation pathway in photoreceptor development and pathology | NIH | National Eye Institute | 2023 to 2025 | $1,138,321 | September 1, 2023 | July 31, 2027 | IVANOV, DMITRY V | reporter.nih.gov |
| Culturally-focused HIV Advancements through the Next Generation for Equity (CHANGE) Training Program | NIH | National Institute of Mental Health | 2021 to 2025 | $1,137,759 | April 1, 2021 | March 31, 2027 | FEASTER, DANIEL J | reporter.nih.gov |
| Symptomatic Toxicities & Quality of Life among Diverse Individuals Receiving Immune Checkpoint Inhibitors for Metastatic Cancer. | NIH | National Cancer Institute | 2025 | $1,131,820 | February 1, 2025 | January 31, 2030 | MORENO, PATRICIA INGRID | reporter.nih.gov |
| Disease Modifying Analgesia with CA8 Gene Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,109,446 | September 16, 2023 | September 30, 2026 | LEVITT, ROY C. | reporter.nih.gov |
| Activation mechanism in HCN channels. | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,101,963 | July 1, 2020 | April 30, 2025 | BARRO-SORIA, RENE | reporter.nih.gov |
| Dynorphin, a novel paracrine factor that regulates insulin secretion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,097,525 | April 17, 2023 | March 31, 2028 | BLANDINO-ROSANO, MANUEL | reporter.nih.gov |
| Comprehensive gene and DNA variant curation for neuromuscular diseases | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,079,672 | June 15, 2021 | May 31, 2025 | ZUCHNER, STEPHAN | reporter.nih.gov |
| Repression via Facultative Heterochromatin | NIH | National Cancer Institute | 2023 to 2025 | $1,075,460 | January 1, 2002 | July 31, 2026 | REINBERG, DANNY | reporter.nih.gov |
| Enhancer RNA Therapy | NIH | National Cancer Institute | 2021 | $1,074,500 | September 30, 2017 | July 31, 2022 | SHIEKHATTAR, RAMIN | reporter.nih.gov |
| A ProgramPharmacy Chains to Increase PrEP Awareness and Access Among Men | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,066,077 | August 18, 2025 | July 31, 2030 | KANAMORI NISHIMURA, MARIANO JUAN | reporter.nih.gov |
| Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL | NIH | National Cancer Institute | 2021 to 2023 | $1,064,045 | April 1, 2019 | March 31, 2025 | LOSSOS, IZIDORE S | reporter.nih.gov |
| A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,059,405 | September 13, 2018 | July 31, 2024 | AGARWAL, ASHUTOSH | reporter.nih.gov |
| Itch-specific brain circuit and dopaminergic gene polymorphisms influencing individual differences in itch perception | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,042,268 | September 1, 2023 | May 31, 2028 | MOCHIZUKI, HIDEKI | reporter.nih.gov |
| Enhancing TET activity for the treatment of hematological malignancy | NIH | National Cancer Institute | 2023 to 2025 | $1,035,837 | August 1, 2023 | July 31, 2028 | CIMMINO, LUISA | reporter.nih.gov |
| The role of PFAS in lipid-mediated vascular contributions to cognitive impairment and dementia: PFAS VascCog Longitudinal Study | NIH | National Institute on Aging | 2024 to 2025 | $1,032,220 | May 15, 2024 | January 31, 2029 | GARDENER, HANNAH | reporter.nih.gov |
| Integrin Activation to Prevent Early Arteriovenous Fistula Failure in End-stage Renal Disease Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,027,600 | February 1, 2024 | January 31, 2028 | VAZQUEZ PADRON, ROBERTO IRENARDO | reporter.nih.gov |
| BMP signaling and regenerative plasticity: Correlating dynamic scRNAseq and real-time anatomical remodeling in T1D pancreatic slices | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,018,876 | January 2, 2024 | December 31, 2028 | DOMINGUEZ-BENDALA, JUAN | reporter.nih.gov |
| Impact of CREB-driven mechanism in shaping the tumor-immune landscape | NIH | National Cancer Institute | 2023 to 2025 | $1,012,439 | January 1, 2023 | December 31, 2027 | NAGATHIHALLI, NAGARAJ S. | reporter.nih.gov |
| SIRT5 inhibitors and degraders as novel treatments for Ewing sarcoma | NIH | National Cancer Institute | 2023 to 2025 | $1,007,447 | January 1, 2023 | December 31, 2027 | LOMBARD, DAVID BENNER | reporter.nih.gov |
| Genetic and Environmental risk of NAFLD-related HCC In All Latinos: the GENIAL Study | NIH | National Cancer Institute | 2023 to 2025 | $1,000,316 | September 21, 2023 | August 31, 2027 | JONES, PATRICIA DENISE | reporter.nih.gov |
| Positive Airway Pressure For The Treatment Of The Obstructive Sleep Apnea Syndrome In Children With Down Syndrome | NIH | National Heart, Lung, and Blood Institute | 2023 | $986,540 | September 1, 2023 | August 31, 2025 | TAPIA, IGNACIO ESTEBAN | reporter.nih.gov |
| CYP17A1-independent androgen synthesis and prostate cancer resistance to next-generation hormonal therapy | NIH | National Cancer Institute | 2023 to 2025 | $967,953 | February 1, 2022 | January 31, 2027 | SHARIFI, NIMA | reporter.nih.gov |
| PRiSM (Pulmonary, Respiratory, and Sleep Medicine) Training Program | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $964,216 | December 1, 2022 | November 30, 2027 | PUNJABI, NARESH M | reporter.nih.gov |
| The Impact of Genetic Ancestry on Racial Disparities in Hepatocellular Carcinoma Risk and Mortality | NIH | National Cancer Institute | 2022 to 2025 | $948,260 | September 15, 2022 | August 31, 2027 | JONES, PATRICIA DENISE | reporter.nih.gov |
| Ovarian Epithelial Cancer Progenitor Cell Population | NIH | National Cancer Institute | 2021 to 2022 | $947,095 | May 10, 2018 | April 30, 2024 | XU, XIANGXI MIKE | reporter.nih.gov |
| Addressing Latino MSM Health Disparities by Increasing Engagement with Behavioral and HIV-Prevention Services: An Implementation Science Approach | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $946,220 | September 25, 2020 | October 31, 2025 | HARKNESS, AUDREY | reporter.nih.gov |
| Oxidative stress response and metabolic reprogramming by protein posttranslational arginylation | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $944,025 | September 1, 2020 | June 30, 2025 | ZHANG, FANGLIANG | reporter.nih.gov |
| Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma | NIH | National Cancer Institute | 2023 to 2025 | $943,450 | March 7, 2023 | February 28, 2026 | BAYIK WATSON, DEFNE | reporter.nih.gov |
| Role of Gut Microbiome in HIV/Opioid Induced Peripheral Neuropathy | NIH | National Institute on Drug Abuse | 2021 to 2022 | $929,035 | July 15, 2018 | May 31, 2024 | ROY, SABITA | reporter.nih.gov |
| Investigating socio-ecological factor in pediatrics sleep-related health Disparities | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $921,255 | September 5, 2020 | August 31, 2025 | TAPIA, IGNACIO ESTEBAN | reporter.nih.gov |
| Disease Modifying Treatment Using Combined Shockwave Therapy and Platelet Rich Plasma In Microvascular Erectile Dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $921,000 | September 21, 2021 | July 31, 2024 | IBRAHIM, EMAD | reporter.nih.gov |
| AKT/mTOR signaling and regulation of cell cycle in B-cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $893,146 | April 11, 2019 | January 31, 2024 | BERNAL-MIZRACHI, ERNESTO | reporter.nih.gov |
| Activation of protein kinases by proline hydroxylation | NIH | National Cancer Institute | 2024 to 2025 | $892,072 | January 5, 2024 | December 31, 2028 | LASORELLA, ANNA | reporter.nih.gov |
| The role of cortisol synthesis in pathogenesis of Hidradenitis suppurativa tunnels | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $885,777 | September 2, 2024 | July 31, 2029 | TOMIC-CANIC, MARJANA | reporter.nih.gov |
| Epigenetic regulation of exhausted CD8 T cells via the miR-29a-TET2 axis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $876,220 | June 21, 2024 | April 30, 2029 | STELEKATI, ERIETTA | reporter.nih.gov |
| Improving Individualized Assessments of Glaucoma Progression with Population-Based Electronic Health Record Data | NIH | National Eye Institute | 2022 to 2025 | $867,552 | June 1, 2022 | March 31, 2027 | SWAMINATHAN, SWARUP SAI | reporter.nih.gov |
| Investigating mechanisms of IL-27-induced photoreceptor protection and rescued vision | NIH | National Eye Institute | 2024 to 2025 | $864,017 | May 1, 2024 | April 30, 2028 | HACKAM, ABIGAIL S | reporter.nih.gov |
| Automated Molecular Identity Disambiguator (AutoMID) | NIH | National Library of Medicine | 2021 to 2023 | $839,910 | May 1, 2020 | February 28, 2025 | SCHURER, STEPHAN C | reporter.nih.gov |
| Cross-disciplinary research opportunity for training in AD/ADRD science (CROSSROADS) | NIH | National Institute on Aging | 2024 to 2025 | $836,404 | June 1, 2024 | May 31, 2029 | RUNDEK, TATJANA | reporter.nih.gov |
| Deciphering the function of DNp63 and MDSCs in tumor promotion and metastasis of TNBCs | NIH | National Cancer Institute | 2022 to 2023 | $835,536 | January 26, 2022 | May 31, 2025 | CHAKRABARTI, RUMELA | reporter.nih.gov |
| Patient Activation and Palliative Care among Hispanics/Latinos with Metastatic Cancer | NIH | National Cancer Institute | 2021 to 2025 | $834,187 | September 1, 2021 | August 31, 2027 | MORENO, PATRICIA INGRID | reporter.nih.gov |
| Circulating urinary microRNAs as systemic biomarkers of healing outcomes in diabetic foot ulcers | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $821,177 | July 4, 2022 | August 31, 2024 | STONE, RIVKA C. | reporter.nih.gov |
| Immune Mechanisms in Ocular Graft versus Host Disease | NIH | National Eye Institute | 2024 to 2025 | $820,020 | May 1, 2014 | March 31, 2027 | PEREZ, VICTOR L | reporter.nih.gov |
| Modulation of KCNQ1 channel activity | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $816,636 | May 1, 2014 | December 31, 2023 | LARSSON, HANS PETER | reporter.nih.gov |
| New carcinogenic mechanisms of Helicobacter pylori infection | NIH | National Cancer Institute | 2021 to 2025 | $778,445 | August 1, 2010 | April 30, 2030 | ZAIKA, ALEXANDER I. | reporter.nih.gov |
| Urban heat island exposure and its impact on Alzheimer’s disease and related dementia outcomes among older adults in South Florida | NIH | National Institute on Aging | 2025 | $777,041 | September 15, 2025 | April 30, 2030 | BESSER, LILAH | reporter.nih.gov |
| Patient-Specific Simulations to Guide Coronary Bifurcation Stenting | NIH | National Heart, Lung, and Blood Institute | 2023 | $770,637 | April 15, 2019 | March 31, 2026 | CHATZIZISIS, IOANNIS S | reporter.nih.gov |
| The Nucleolar Detention Center: a Hub of Long Noncoding RNAs that Imprison Proteins During Stress | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $768,643 | July 24, 2015 | February 28, 2025 | LEE, STEPHEN | reporter.nih.gov |
| Development of human inner ear organoid platforms for human auditory/vestibular disorders | NIH | National Institute on Deafness and Other Communication Disorders | 2025 | $767,494 | January 1, 2025 | December 31, 2029 | LIU, XUE Z | reporter.nih.gov |
| Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy | NIH | National Cancer Institute | 2021 to 2022 | $759,825 | April 1, 2012 | January 31, 2024 | MERCHANT, NIPUN B. | reporter.nih.gov |
| Circulating urinary microRNAs as systemic biomarkers of healing outcomes in diabetic foot ulcers | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $759,432 | July 4, 2022 | August 31, 2027 | STONE, RIVKA C. | reporter.nih.gov |
| Protective role of CXCR7 in neonatal hyperoxia-induced systemic vascular dysfunction in adulthood | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $747,360 | August 7, 2021 | July 31, 2026 | BENNY, MERLINE | reporter.nih.gov |
| New computational tools for understanding and predicting AD via age-associated DNA methylation changes | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $747,336 | September 15, 2022 | August 31, 2027 | WANG, LILY | reporter.nih.gov |
| Targeting the IL-33/ST2 Pathway in Colorectal Cancer Immunotherapy | NIH | National Cancer Institute | 2023 to 2025 | $747,000 | February 1, 2023 | January 31, 2026 | VAN DER JEUGHT, KEVIN | reporter.nih.gov |
| Predoctoral Training in Translational Immunology | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $744,909 | August 15, 2022 | July 31, 2027 | MALEK, THOMAS R | reporter.nih.gov |
| Miami Otolaryngology Surgeon-Scientist Training Program (MOSSTP) | NIH | National Institute on Deafness and Other Communication Disorders | 2023 to 2025 | $742,143 | July 1, 2023 | June 30, 2028 | DINH, CHRISTINE THUYVAN | reporter.nih.gov |
| Glycosaminoglycan-enabled technologies to reprogram chronic inflammatory states | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $735,500 | September 1, 2024 | June 30, 2029 | DUMONT, COURTNEY MARGARET | reporter.nih.gov |
| Biobehavioral Predictors of Illness Progression in Adolescent Depression | NIH | National Institute of Mental Health | 2024 | $732,647 | April 1, 2020 | January 31, 2026 | GABBAY, VILMA | reporter.nih.gov |
| Immunoglobulins Delivered by AVV Vector for the Prevention of SIV Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $731,021 | July 18, 2012 | November 30, 2021 | DESROSIERS, RONALD C | reporter.nih.gov |
| MUSICA - MUsic and Speech Induced Cerebral Activation | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $728,352 | June 1, 2022 | May 31, 2027 | ALKHACHROUM, AYHAM | reporter.nih.gov |
| Novel medical adjunctive therapy to catheter ablation for atrial fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 | $719,937 | February 15, 2019 | January 31, 2024 | GOLDBERGER, JEFFREY J | reporter.nih.gov |
| The Neural Underpinnings of Depression and Cannabis Use in Young PLWH | NIH | National Institute on Drug Abuse | 2024 | $709,068 | September 1, 2021 | July 31, 2026 | GABBAY, VILMA | reporter.nih.gov |
| Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy | NIH | National Cancer Institute | 2024 to 2025 | $702,262 | April 4, 2024 | March 31, 2029 | XU, XIANGXI MIKE | reporter.nih.gov |
| Understanding mechanisms of BTK inhibitor and degrader resistance in patients with chronic lymphocytic leukemia | NIH | National Cancer Institute | 2024 to 2025 | $702,262 | July 1, 2024 | June 30, 2029 | TAYLOR, JUSTIN | reporter.nih.gov |
| Disrupting MDSC-fibroblast interactions to overcome chemoimmunotherapy resistance in pancreatic cancer | NIH | National Cancer Institute | 2024 to 2025 | $702,262 | August 28, 2024 | July 31, 2029 | DATTA, JASHODEEP | reporter.nih.gov |
| Defining the Biological and Mechanistic Implications of XPO1 Mutations in Hematologic Malignancies | NIH | National Cancer Institute | 2021 to 2023 | $702,046 | August 1, 2018 | January 31, 2024 | TAYLOR, JUSTIN | reporter.nih.gov |
| Greenness, Cognitive Performance and Vascular Outcomes in the NOMAS Study | NIH | National Institute on Aging | 2024 | $696,046 | September 30, 2021 | August 31, 2025 | BROWN, SCOTT CHARLES | reporter.nih.gov |
| The role of NRF2 in reflux-induced esophageal adenocarcinomas | NIH | National Cancer Institute | 2021 to 2022 | $695,242 | February 1, 2018 | January 31, 2024 | EL-RIFAI, WAEL | reporter.nih.gov |
| Disparities in Transition of Care after Acute Stroke Hospitalization: The Transition of Care Stroke Disparity Study (TCSD-S) | NIH | National Institute on Minority Health and Health Disparities | 2021 | $692,213 | September 26, 2017 | June 30, 2024 | ROMANO, JOSE G | reporter.nih.gov |
| A new pathway of spinal neurons in neuropathic pain induced by HIV with opioid | NIH | National Institute on Drug Abuse | 2021 to 2022 | $690,750 | September 30, 2018 | July 31, 2024 | HAO, SHUANGLIN | reporter.nih.gov |
| mCARES: An HIV Adherence Intervention to Support Racial/Ethnic Minority Women with/at-risk of Substance Use and Mental Health Disorders | NIH | National Institute on Drug Abuse | 2022 to 2024 | $689,520 | September 30, 2022 | July 31, 2025 | DUTHELY, LUNTHITA M | reporter.nih.gov |
| Radioimmunotherapy Combinations for B-cell Malignancy | NIH | National Cancer Institute | 2024 to 2025 | $688,017 | January 1, 1998 | July 31, 2026 | GREEN, DAMIAN J. | reporter.nih.gov |
| Targeting Estrogenic pathways in Tregs to promote ARDS resolution - 5R01HL163881 | NIH | National Heart, Lung, and Blood Institute | 2025 | $684,280 | August 15, 2025 | May 31, 2027 | D'ALESSIO, FRANCO RAFAEL | reporter.nih.gov |
| Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma | NIH | National Cancer Institute | 2021 to 2022 | $675,447 | January 1, 2018 | December 31, 2024 | RAMOS, JUAN CARLOS | reporter.nih.gov |
| UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies | NIH | National Cancer Institute | 2021 to 2022 | $671,059 | September 20, 2017 | August 31, 2024 | RAMOS, JUAN CARLOS | reporter.nih.gov |
| Targeting gut inflammation through diet: a tailored American diet for patients with ulcerative colitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $667,726 | September 1, 2024 | June 30, 2029 | DAMAS, ORIANA MAZORRA | reporter.nih.gov |
| Quantitative Dynamic Monitoring of MSCs and MSC-EVs in a Mouse Model of Intracerebral Hemorrhage | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $663,854 | August 1, 2025 | April 30, 2029 | KUDDANNAYA, SHREYAS | reporter.nih.gov |
| Interplay Between Langerhans Cells and Sensory Neurons: Impact on Wound Healing and Nociception Following Burn Injuries | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $660,050 | September 15, 2024 | July 31, 2028 | AKIYAMA, TASUKU | reporter.nih.gov |
| The neuronal circuits of affective itch | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $659,296 | July 27, 2018 | May 31, 2024 | AKIYAMA, TASUKU | reporter.nih.gov |
| Multidisciplinary Training in Substance Abuse Research | NIH | National Institute on Drug Abuse | 2021 to 2023 | $654,578 | July 1, 2019 | June 30, 2025 | ROY, SABITA | reporter.nih.gov |
| Developing a kinase inhibitor drug to treat spinal cord injury | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $650,295 | February 4, 2022 | January 31, 2023 | AL-ALI, HASSAN | reporter.nih.gov |
| Role of HSP70 in Pancreatic Diseases | NIH | National Cancer Institute | 2021 to 2022 | $649,650 | September 24, 2007 | April 30, 2024 | RAMAKRISHNAN, SUNDARAM | reporter.nih.gov |
| The impact of diet patterns and PUFA-related polymorphisms on ulcerative colitis in Hispanics | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $645,408 | January 14, 2019 | May 31, 2025 | DAMAS, ORIANA MAZORRA | reporter.nih.gov |
| Neurotoxicity of Spermine Synthase-deficiency and Polyamine Imbalance | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $643,196 | September 30, 2018 | June 30, 2023 | ZHAI, RONG GRACE | reporter.nih.gov |
| In situ analysis of functional endocrine, vascular, and immune cell interactions during early postnatal development of the human pancreas | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $632,286 | September 25, 2018 | June 30, 2023 | CAICEDO, ALEJANDRO | reporter.nih.gov |
| Immunomodulatory drug interventions for the prevention of host immune responses toward AAV-delivered anti-HIV antibodies | NIH | Office of the Director, National Institutes of Health | 2025 | $630,197 | February 1, 2025 | January 31, 2027 | FUCHS, SEBASTIAN PATRICK | reporter.nih.gov |
| Molecular Predictive Testing in Ocular Melanoma | NIH | National Cancer Institute | 2021 | $626,898 | July 1, 2006 | March 31, 2023 | CORREA, ZELIA MARIA | reporter.nih.gov |
| Control of cell morphogenesis and cell growth by conserved NDR kinase Orb6 | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $614,000 | September 23, 2019 | July 31, 2024 | VERDE, FULVIA | reporter.nih.gov |
| Aberrant tumor metabolism that enables AR antagonist-resistant prostate cancer | NIH | National Cancer Institute | 2023 to 2024 | $607,655 | December 1, 2019 | November 30, 2024 | SHARIFI, NIMA | reporter.nih.gov |
| Genetic and Phenotypic Analysis of Multiple Sclerosis in Hispanics | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $607,398 | August 1, 2016 | May 31, 2023 | MCCAULEY, JACOB L | reporter.nih.gov |
| Role of NFKBIA Deficiency in Subverting Neural Progenitor Commitment Toward Gliomagenesis | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $599,005 | August 21, 2025 | July 31, 2030 | BREDEL, MARKUS | reporter.nih.gov |
| Effectiveness of Low-dose Theophylline for the Management of biomass-associated COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $590,723 | July 15, 2019 | June 30, 2025 | SIDDHARTHAN, TRISHUL | reporter.nih.gov |
| Acquisition of a Leica Stellaris 5 Upright Confocal Microscope for In Vivo Imaging Applications | NIH | Office of the Director, National Institutes of Health | 2025 | $590,000 | August 1, 2025 | July 31, 2026 | ABDULREDA, MIDHAT H | reporter.nih.gov |
| Novel Molecular Functions of WEE1 in Esophageal Adenocarcinoma | NIH | National Cancer Institute | 2021 to 2023 | $574,776 | August 1, 2021 | July 31, 2024 | CHEN, ZHENG | reporter.nih.gov |
| ISCHEMIC PRECONDITIONING: MECHANISMS OF NEUROPROTECTION | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $569,374 | May 1, 1997 | August 31, 2027 | PEREZ-PINZON, MIGUEL A | reporter.nih.gov |
| Exploring minorities The Undiagnosed Diseases Network Clinical Site of Miami | NIH | National Human Genome Research Institute | 2021 | $550,000 | September 21, 2018 | April 30, 2023 | TEKIN, MUSTAFA | reporter.nih.gov |
| Autoinducer-2 and depression | NIH | National Institute of Mental Health | 2025 | $549,140 | December 1, 2024 | November 30, 2029 | BEUREL, ELEONORE | reporter.nih.gov |
| Cancer Epigenetics Training Program | NIH | National Cancer Institute | 2021 to 2022 | $542,751 | August 1, 2018 | July 31, 2024 | FIGUEROA, MARIA EUGENIA | reporter.nih.gov |
| Relative Contribution of Trypsin and Inflamation in Acute and Chronic Pancreatitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $540,673 | August 1, 2011 | March 31, 2024 | DAWRA, RAJINDER K | reporter.nih.gov |
| Longitudinal Imaging and Liquid Biopsy Markers of Prostate Cancer Radiotherapy Outcomes | NIH | National Cancer Institute | 2025 | $538,553 | April 1, 2025 | March 31, 2030 | POLLACK, ALAN | reporter.nih.gov |
| Vascular Determinants of Dementia and Cognitive Decline in a Tri-Ethnic Region | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $537,250 | January 7, 1993 | August 31, 2023 | RUNDEK, TATJANA | reporter.nih.gov |
| Global Alzheimer’s and Dementia Partnership to Advance Neuroscience in LMICs (GAP-ADN) | NIH | National Institute on Aging | 2025 | $536,527 | August 15, 2025 | July 31, 2030 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| The Role of Osteopontin-OGDHL Axis in HFpEF | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $535,632 | February 1, 2018 | November 30, 2022 | SHEHADEH, LINA A | reporter.nih.gov |
| Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease | NIH | National Heart, Lung, and Blood Institute | 2022 | $533,251 | May 24, 2022 | April 30, 2023 | VELAZQUEZ, OMAIDA C | reporter.nih.gov |
| Exosomal-mediated pyroptosis in ventilation-associated preterm brain injury | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $533,166 | July 15, 2020 | December 31, 2024 | SANTOS SCHMIDT, AUGUSTO F | reporter.nih.gov |
| Impact of miRNAs on adult neurogenesis following exposure to methamphetamine and HIV-1 Infection | NIH | National Institute on Drug Abuse | 2024 to 2025 | $529,515 | April 1, 2024 | March 31, 2027 | PARK, MIN SEON | reporter.nih.gov |
| Reprogrammed Monocytes Improve Neovascularization in Peripheral Arterial Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $528,179 | March 4, 2025 | May 1, 2025 | LASSANCE-SOARES, ROBERTA MARQUES | reporter.nih.gov |
| Targeted degradation of proteins by affinity peptide conjugated ubiquitin (APCU) | NIH | National Cancer Institute | 2021 to 2023 | $527,504 | April 12, 2021 | March 31, 2024 | ZHANG, FANGLIANG | reporter.nih.gov |
| Role of Microbial dysbiosis and altered metabolomics in the context of Opioid abuse and ART in HIV disease progression | NIH | National Institute on Drug Abuse | 2021 | $504,127 | March 1, 2017 | January 31, 2023 | ROY, SABITA | reporter.nih.gov |
| Full-scale GMP Production for a Pre-Clinical Systemic Delivered Mesenchymal Stem Cells Derived Extracellular Vesicles For Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $502,236 | August 1, 2023 | July 31, 2025 | HARE, JOSHUA M | reporter.nih.gov |
| The Role of Microbiome Modulation in Morphine-Induced Exacerbation of Pancreatitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $501,885 | June 1, 2018 | March 31, 2024 | ROY, SABITA | reporter.nih.gov |
| Tumor-Mediated Hearing Loss in Neurofibromatosis Type II | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2023 | $501,293 | December 1, 2018 | November 30, 2024 | DINH, CHRISTINE THUYVAN | reporter.nih.gov |
| Microbial Dysbiosis and TLR2 Activation Contribute to Immune Activation, Inflammation and HIV Persistence in the Context of Opioid Abuse Despite ART Therapy | NIH | National Institute on Drug Abuse | 2021 | $499,558 | July 1, 2017 | May 31, 2023 | ROY, SABITA | reporter.nih.gov |
| Cardiovascular Research Empowerment Workforce | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $498,909 | August 3, 2023 | July 31, 2028 | KENYA, SONJIA | reporter.nih.gov |
| Adolescent exposure to PCBs as a risk factor for the development of depression | NIH | National Institute of Environmental Health Sciences | 2025 | $495,980 | December 17, 2024 | October 31, 2029 | TOBOREK, MICHAL | reporter.nih.gov |
| Workshops and Coaching to Foster Career Skills in Newly Funded NIDDK Scholars | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $486,000 | September 1, 2023 | June 30, 2028 | FORNONI, ALESSIA | reporter.nih.gov |
| Targeting Multiple Kinases to Treat Experimental Spinal Cord Injury. | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $482,245 | July 1, 2017 | April 30, 2023 | LEMMON, VANCE P | reporter.nih.gov |
| Molecular Organization of the First Visual Synapse | NIH | National Eye Institute | 2025 | $477,756 | April 1, 2007 | December 31, 2026 | MARTEMYANOV, KIRILL A. | reporter.nih.gov |
| Eosinophilic Mucin Chronic Rhinosinusitis: Determining the multi-level factors that mediate disease and disparities | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $463,320 | July 7, 2023 | January 31, 2028 | LEVINE, CORINNA GEHRETT | reporter.nih.gov |
| Predicting the risk of glaucoma from structural, functional, and genetic factors using artificial intelligence | NIH | National Eye Institute | 2025 | $462,313 | April 1, 2022 | March 31, 2027 | YOUSEFI, SIAMAK | reporter.nih.gov |
| Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $460,500 | April 1, 2024 | March 31, 2029 | QUESADA MASACHS, ESTEFANIA | reporter.nih.gov |
| Cellular Mechanisms of Mac-1 Mediated Atheroprotection | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $460,028 | May 18, 2020 | April 30, 2025 | MARTINEZ, LAISEL | reporter.nih.gov |
| Role of Yersinia pestis Ail-host ligand interactions in plague | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $450,096 | February 1, 2017 | July 17, 2022 | PLANO, GREGORY V | reporter.nih.gov |
| Epigenetic dependencies and vulnerabilities in endocrine-resistant breast cancer | NIH | National Cancer Institute | 2025 | $447,340 | March 1, 2025 | February 28, 2030 | MOREY, LLUIS | reporter.nih.gov |
| Cell fate determination in the early development of the otic lineage in human inner ear organoids | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2023 | $447,125 | July 5, 2021 | June 30, 2024 | TANG, PEI-CIAO | reporter.nih.gov |
| The role of PLIN5 deficiency in podocyte lipotoxicity and progression of Alport Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $442,792 | January 1, 2022 | December 31, 2026 | KIM, JINJU | reporter.nih.gov |
| NOVEL INNATE MECHANISMS OF IMMUNE TOLERANCE INDUCTION IN ALLOGENEIC HCT FOR HEMOGLOBINOPATHIES | NIH | National Heart, Lung, and Blood Institute | 2021 | $441,168 | January 1, 2018 | December 31, 2022 | PILLAI, ASHA BHASKARAN | reporter.nih.gov |
| Assessing multifactorial etiology of overactive bladder using a novel PFM-Hip-Trunk muscle network analysis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $440,651 | September 1, 2023 | August 31, 2025 | ZHANG, YINGCHUN | reporter.nih.gov |
| Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection | NIH | National Institute on Drug Abuse | 2024 to 2025 | $439,280 | May 15, 2024 | April 30, 2027 | ROY, SABITA | reporter.nih.gov |
| Associations between neighborhood environments across the life course and Alzheimer's disease and related dementia outcomes among Hispanic older adults born in and outside the US | NIH | National Institute on Aging | 2024 to 2025 | $435,054 | August 1, 2024 | June 30, 2027 | BESSER, LILAH | reporter.nih.gov |
| Health Effects of Hurricane Ian | NIH | National Institute of Environmental Health Sciences | 2023 | $434,683 | June 13, 2023 | May 31, 2025 | KUMAR, NARESH | reporter.nih.gov |
| Impact of Parental Bereavement on Social Connection, Isolation, and Health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $434,596 | September 1, 2024 | August 31, 2026 | LICHTENTHAL, WENDY G. | reporter.nih.gov |
| Jump Start to Talk: Understanding Diverse Perspectives from Parents and Teachers to Rethink and Improve Identification, Referral, and Service for Dual Language Learner Late Talkers. | NIH | National Institute on Deafness and Other Communication Disorders | 2025 | $432,893 | September 1, 2025 | August 31, 2027 | SCHLANDANT, MICHELLE | reporter.nih.gov |
| Tissue-engineered lymph node stroma to study peripheral tolerance in autoimmune diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $432,804 | December 1, 2020 | November 30, 2022 | TOMEI, ALICE | reporter.nih.gov |
| Overcoming preexisting antibodies to recombinant AAV vectors in rhesus macaques | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $432,049 | April 5, 2024 | February 28, 2027 | MARTINEZ-NAVIO, JOSE MARIA | reporter.nih.gov |
| Summer Research Experience in Biological and Computational Sciences | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $430,604 | September 30, 2014 | December 31, 2025 | VANCE, JEFFERY MARVIN | reporter.nih.gov |
| COVERT– COvert Volitional Eye Response Test | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $428,097 | September 21, 2022 | August 31, 2024 | ALKHACHROUM, AYHAM | reporter.nih.gov |
| Efficacy assessment of intraocular islet transplant in nonhuman primates | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $422,125 | April 19, 2021 | March 31, 2024 | ABDULREDA, MIDHAT H | reporter.nih.gov |
| Analyzing the expression and activation of Perforin-2 -a bactericidal pore-forming protein- with single domain antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $422,125 | December 17, 2020 | November 30, 2023 | MUNSON, GEORGE PATRICK | reporter.nih.gov |
| Identification of Protein-Protein Interactions and Processing Events That Traffic and Activate the Bactericidal Pore-Forming Protein Perforin-2 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $422,125 | February 18, 2021 | January 31, 2024 | MUNSON, GEORGE PATRICK | reporter.nih.gov |
| Targeting polymicrobial infections of diabetic foot ulcers with a novel antimicrobial peptide therapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $422,125 | February 3, 2021 | January 31, 2025 | AJDIC, DRAGANA | reporter.nih.gov |
| Regeneration-permissive glia after spinal cord injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $422,125 | August 1, 2021 | January 31, 2024 | LEE, JAE K | reporter.nih.gov |
| Use of use of dimethyl fumarate for targeting autoimmunity in type 1 diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $422,125 | September 24, 2021 | August 31, 2024 | VENDRAME, FRANCESCO | reporter.nih.gov |
| Bi-functional fusion proteins to regulate autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $422,125 | November 17, 2021 | October 31, 2024 | MALEK, THOMAS R | reporter.nih.gov |
| Aptamer specific for myeloid derived suppressor cells for the diagnosis of head and neck cancer from the oral rinse | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2024 | $422,125 | March 15, 2023 | March 14, 2026 | SERAFINI, PAOLO | reporter.nih.gov |
| Irreversible Proviral Silencing in Myeloid Cells | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $422,125 | August 2, 2023 | July 31, 2025 | STEVENSON, MARIO | reporter.nih.gov |
| Investigating Genomic Instability and Loss of the Y Chromosome in Alzheimer’s Disease | NIH | National Institute on Aging | 2023 | $422,125 | September 1, 2023 | August 31, 2025 | CUKIER, HOLLY N | reporter.nih.gov |
| Creating an advanced multi-ancestral resource and tools for short tandem repeat analysis in the AOURP researcher workbench | NIH | National Human Genome Research Institute | 2023 | $422,125 | September 15, 2023 | August 31, 2025 | DANZI, MATTHEW CHRISTOPHER | reporter.nih.gov |
| MRS DITCH - Magnetic Resonance Selection with DIffusion Tensor Imaging in Cerebral Hemorrhage | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $422,125 | February 15, 2024 | January 31, 2026 | KOCH, SEBASTIAN | reporter.nih.gov |
| Developing a high-throughput panel for rapid detection of pathogens causing infectious keratitis | NIH | National Eye Institute | 2024 to 2025 | $422,125 | June 1, 2024 | May 31, 2027 | KURTENBACH, STEFAN | reporter.nih.gov |
| Glia in Aging | NIH | National Institute on Aging | 2024 to 2025 | $422,125 | September 1, 2024 | May 31, 2027 | BIANCHI, LAURA | reporter.nih.gov |
| Modeling the effect of outdoor air pollution on the health and function of the retina | NIH | National Eye Institute | 2024 to 2025 | $422,125 | August 1, 2024 | July 31, 2027 | HACKAM, ABIGAIL S | reporter.nih.gov |
| CCL2/CCR2 modulates HIV-associated ischemic stroke by regulating blood brain barrier monocyte recruitment | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $422,125 | September 18, 2024 | August 31, 2026 | TORICES, SILVIA | reporter.nih.gov |
| Targeting cholesterol homeostasis for therapy of demyelinating eye disease | NIH | National Eye Institute | 2025 | $422,125 | August 1, 2025 | July 31, 2027 | BRAMBILLA, ROBERTA | reporter.nih.gov |
| Investigating chromatin mechanisms using viral systems | NIH | National Institute of General Medical Sciences | 2025 | $422,125 | September 1, 2019 | July 31, 2029 | AVGOUSTI, DAPHNE CHRISTINA | reporter.nih.gov |
| Delivering miR-29a to enhance anti-viral and anti-tumor responses in vivo | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $415,218 | February 15, 2024 | December 31, 2025 | STELEKATI, ERIETTA | reporter.nih.gov |
| Spinal Cord Injury Exercise and Nutrition Conceptual Engagement (SCIENCE) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $415,063 | September 1, 2017 | May 31, 2022 | GATER, DAVID R | reporter.nih.gov |
| Role of Langerhans Cell-Sensory Neuron Interactions in Wound Healing and Nociception After Burn Injury | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $410,000 | September 21, 2022 | August 31, 2024 | AKIYAMA, TASUKU | reporter.nih.gov |
| Role of gasderminD in ganglion cell dysfunction and injury | NIH | National Eye Institute | 2021 to 2022 | $407,463 | February 1, 2021 | January 31, 2024 | SHESTOPALOV, VALERY I | reporter.nih.gov |
| Prevention of HIV and drug abuse-induced brain pathology by targeting mitochondria | NIH | National Institute on Drug Abuse | 2021 | $404,557 | July 1, 2017 | May 31, 2023 | TOBOREK, MICHAL | reporter.nih.gov |
| Mechanisms of ID2 regulation in glioma | NIH | National Cancer Institute | 2022 to 2023 | $394,748 | April 1, 2019 | August 31, 2024 | LASORELLA, ANNA | reporter.nih.gov |
| Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia | NIH | National Cancer Institute | 2023 | $394,687 | August 23, 2023 | July 31, 2025 | PAUS, RALF | reporter.nih.gov |
| Aptamer mediated silencing of the spliceosome machinery to increase the immunogenicity of metastatic breast cancer | NIH | National Cancer Institute | 2021 to 2022 | $390,381 | August 4, 2021 | July 31, 2023 | SERAFINI, PAOLO | reporter.nih.gov |
| Understanding drivers of incident hypertension disparities among US Hispanics of diverse backgrounds | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2022 | $386,882 | August 1, 2019 | February 29, 2024 | ELFASSY, TALI | reporter.nih.gov |
| University of MIami Neurosurgery eDucation Strategy UMINDS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $385,824 | September 1, 2019 | August 31, 2029 | LEVI, ALLAN D. | reporter.nih.gov |
| Visual impairment and cognitive decline: understanding the longitudinal relationships and mechanisms | NIH | National Institute on Aging | 2023 to 2025 | $384,654 | January 1, 2023 | December 31, 2027 | ZHENG, DANDAN DIANE | reporter.nih.gov |
| Role of TOCA proteins in glia: from cellular morphology to animal behavior | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $384,007 | April 1, 2024 | March 31, 2026 | BIANCHI, LAURA | reporter.nih.gov |
| A Phase 2 biomarker driven, Study of DB107, a Retroviral Replicating Vector, Combined With 5-FC in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma | NIH | National Cancer Institute | 2023 to 2024 | $383,923 | July 14, 2023 | June 30, 2026 | SHAH, ASHISH HARISH | reporter.nih.gov |
| Noninvasive monitoring of therapeutic response to immune checkpoint inhibitors using circulating exosomes in non-small cell lung cancer | NIH | National Cancer Institute | 2023 to 2024 | $383,923 | July 19, 2023 | June 30, 2025 | DAUNERT, SYLVIA | reporter.nih.gov |
| Novel noninvasive high-resolution in vivo imaging platform to study the thyroid gland physiology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $383,750 | July 21, 2020 | April 30, 2023 | SAAR WERNECK DE CASTRO, JOAO PEDRO | reporter.nih.gov |
| Understand Glycation: The Sweet Side of Protein Regulation | NIH | National Institute of General Medical Sciences | 2022 | $383,750 | July 1, 2022 | April 30, 2023 | SANGHVI, VIRAJ | reporter.nih.gov |
| Mitochondrial transfer from astrocytes to glioblastoma cells drives tumor growth | NIH | National Cancer Institute | 2024 to 2025 | $382,514 | April 3, 2023 | April 30, 2027 | WATSON, DIONYSIOS C | reporter.nih.gov |
| PS03, a bifunctional RNA therapeutic to induce exhaustion in diabetogenic T cells | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $380,000 | August 1, 2025 | January 31, 2027 | SERAFINI, PAOLO | reporter.nih.gov |
| C-KIT SIGNALING IN COLLATERALS REMODELING | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $379,104 | January 17, 2019 | December 31, 2023 | LASSANCE-SOARES, ROBERTA MARQUES | reporter.nih.gov |
| Objectively measured neighborhood greenness in midlife and late life cognitive and brain imaging outcomes for Alzheimer's disease: The Multi-Ethnic Study of Atherosclerosis | NIH | National Institute on Aging | 2022 | $378,884 | May 15, 2022 | April 30, 2026 | BESSER, LILAH | reporter.nih.gov |
| Medical Scientist Training Program | NIH | National Institute of General Medical Sciences | 2021 | $376,239 | July 1, 2017 | June 30, 2022 | LEMMON, SANDRA K. | reporter.nih.gov |
| Mechanisms of optic nerve regeneration | NIH | National Eye Institute | 2021 | $372,237 | April 1, 2017 | March 31, 2023 | HACKAM, ABIGAIL S | reporter.nih.gov |
| CD10-bound Exosomes from IFP-MSC Degrade Substance P Controlling OA Inflammation and Pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $371,470 | July 18, 2022 | June 30, 2024 | KOUROUPIS, DIMITRIOS | reporter.nih.gov |
| Developing biomarkers of healing and non-healing VLUs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $371,470 | September 18, 2023 | August 31, 2025 | JOZIC, IVAN | reporter.nih.gov |
| Use of NMNAT chaperone activity against Alzheimer related proteinpathy. | NIH | National Institute on Aging | 2021 to 2023 | $370,737 | February 1, 2019 | February 29, 2024 | PINTO, MILENA | reporter.nih.gov |
| Catheter-associated molecular patterns and arteriovenous fistula failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $364,563 | January 22, 2024 | April 30, 2025 | MARTINEZ, LAISEL | reporter.nih.gov |
| Extracellular RNA Expression Biomarkers in Osteoarthritis Disease and Progression | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $364,286 | February 22, 2023 | January 31, 2026 | GRISWOLD, ANTHONY JOHN | reporter.nih.gov |
| Electronic Nicotine Delivery Systems (ENDS) Use and Access in Florida's Tobacco Regulatory Environment | NIH | National Cancer Institute | 2021 to 2023 | $361,999 | September 1, 2021 | September 15, 2023 | BAILEY, ZINZI DIANA | reporter.nih.gov |
| Use of Continuous Glucose Monitoring (CGM) in End-Stage Renal Disease(ESRD) Patients with Type 2 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $361,445 | February 15, 2020 | June 14, 2025 | GALINDO, RODOLFO | reporter.nih.gov |
| How do obesity and related inflammation decrease antibody responses in aging? | NIH | National Institute on Aging | 2021 | $360,725 | February 1, 2005 | May 31, 2023 | BLOMBERG, BONNIE B. | reporter.nih.gov |
| Role of Dopamine Neuron-Specific Gene Enhancers in Cocaine Relapse | NIH | National Institute on Drug Abuse | 2021 to 2022 | $359,310 | February 15, 2019 | July 31, 2023 | TUESTA, LUIS MIGUEL | reporter.nih.gov |
| SMPDL3b and podocyte insulin signaling in DKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $345,375 | March 12, 2018 | February 28, 2022 | FORNONI, ALESSIA | reporter.nih.gov |
| 7-7-Collaborative genomic studies of Tourette Disorder | NIH | National Institute of Mental Health | 2021 to 2022 | $344,687 | June 10, 2018 | March 31, 2024 | COFFEY, BARBARA JANE | reporter.nih.gov |
| High-Density Surface Electromyography Guided Precision Botulinum Neurotoxin Injections to Manage Chronic Pelvic Floor Pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $341,988 | June 4, 2024 | June 30, 2025 | ZHANG, YINGCHUN | reporter.nih.gov |
| Development of neurologic itch signature | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $341,857 | June 1, 2021 | May 31, 2025 | MOCHIZUKI, HIDEKI | reporter.nih.gov |
| Metabolic Master Regulators for Ischemic Neuroprotection | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $335,781 | August 15, 2017 | October 31, 2023 | PEREZ-PINZON, MIGUEL A | reporter.nih.gov |
| Unraveling the tolerogenic potential of lymph node fibroblastic reticular networks in autoimmune diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $332,231 | August 1, 2022 | July 31, 2024 | TOMEI, ALICE | reporter.nih.gov |
| Virtual Reality Intervention for Stress, Resilience, and Blood Pressure Management in Black Women | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $331,614 | August 1, 2024 | July 31, 2029 | BLANC, JUDITE | reporter.nih.gov |
| Induction and characterization of RGC axon regeneration in models of glaucoma | NIH | National Eye Institute | 2021 to 2022 | $319,782 | September 1, 2021 | September 7, 2023 | PARK, KEVIN KYUNG | reporter.nih.gov |
| Mitochondrial transfer from astrocytes to glioblastoma cells drives tumor growth | NIH | National Cancer Institute | 2023 to 2024 | $319,200 | April 3, 2023 | April 30, 2024 | WATSON, DIONYSIOS C | reporter.nih.gov |
| The microbiota, a possible link between Th17 cells and depression | NIH | National Institute of Mental Health | 2021 | $307,000 | March 15, 2017 | January 31, 2023 | BEUREL, ELEONORE | reporter.nih.gov |
| Role of TRF2 in DNA recombination | NIH | National Institute of General Medical Sciences | 2021 | $307,000 | February 1, 2017 | January 31, 2023 | VERDUN, RAMIRO ERNESTO | reporter.nih.gov |
| In vivo effects of physical exercise on human islet structure and function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $307,000 | July 1, 2021 | June 30, 2024 | SAAR WERNECK DE CASTRO, JOAO PEDRO | reporter.nih.gov |
| Portable, Rapid, Multiplexed Flow strip Test for Bacteria | NIH | National Institute of General Medical Sciences | 2021 | $303,163 | August 1, 2018 | April 30, 2024 | DEO, SAPNA K | reporter.nih.gov |
| Apico-basal Polarity Signaling Controls Expression of Epithelial Cyrokines Through NF-kB | NIH | National Institute of General Medical Sciences | 2021 | $299,325 | June 1, 2018 | March 31, 2023 | SALAS, PEDRO | reporter.nih.gov |
| Translational Research Training in Gastroenterology and Hepatology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $278,686 | May 1, 2018 | April 30, 2024 | ABREU, MARIA TERESA | reporter.nih.gov |
| Dissecting spatiotemporal heterogeneity of glioblastoma evolution under therapy | NIH | National Cancer Institute | 2024 to 2025 | $277,397 | February 1, 2024 | March 31, 2026 | MIGLIOZZI, SIMONA | reporter.nih.gov |
| Comparative Safety of Pain Medications | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $265,142 | April 1, 2019 | February 28, 2025 | CHUNG, CECILIA PILAR | reporter.nih.gov |
| 4/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $253,439 | August 20, 1994 | January 31, 2023 | GOLDBERG, RONALD B | reporter.nih.gov |
| Prospects for hepatitis C elimination in networks of people who inject drugs through improvements in the care continuum | NIH | National Institute on Drug Abuse | 2025 | $249,000 | February 1, 2023 | May 31, 2028 | ZHU, LIN | reporter.nih.gov |
| Longitudinal associations between neighborhood greenspace and brain aging in cognitively normal older adults | NIH | National Institute on Aging | 2023 to 2024 | $248,778 | May 15, 2020 | January 31, 2026 | BESSER, LILAH | reporter.nih.gov |
| The importance of Lysyl Oxidase in Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $245,546 | February 1, 2022 | January 31, 2025 | STOYELL-CONTI, FILIPE FERNANDES | reporter.nih.gov |
| Collaborative Research: Modernizing Mixed Model Prediction | NSF | Division Of Mathematical Sciences | 2022 | $238,250 | September 1, 2022 | October 31, 2024 | Jonnagadda S Rao | nsf.gov |
| Evaluating Mitochondrial Quality Control in the Outflow Facility | NIH | National Eye Institute | 2025 | $236,576 | August 1, 2025 | July 31, 2030 | PHAM, ANH HOANG | reporter.nih.gov |
| A Personalized Medicine Approach to Improve the Prediction of Azathioprine Toxicity | NIH | National Institute of General Medical Sciences | 2022 | $235,870 | September 1, 2018 | July 31, 2025 | CHUNG, CECILIA PILAR | reporter.nih.gov |
| Development and Maintenance of Software for MR Spectroscopic Imaging | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 | $235,080 | September 20, 2013 | June 30, 2022 | MAUDSLEY, ANDREW A. | reporter.nih.gov |
| A tolerogenic approach for the long-term delivery of antibodies with AAV | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $231,775 | March 6, 2020 | February 28, 2025 | MARTINEZ-NAVIO, JOSE MARIA | reporter.nih.gov |
| Adaptive intervention strategies to optimize PrEP clinical evaluation and uptake in stimulant-using men | NIH | National Institute on Drug Abuse | 2021 | $231,275 | February 15, 2019 | January 31, 2023 | CARRICO, ADAM WAYNE | reporter.nih.gov |
| Characterizing the serum metabolome in multiple sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $230,826 | August 7, 2023 | March 31, 2025 | BRIGGS, FARREN B. S. | reporter.nih.gov |
| HIGH-RESOLUTION CHARACTERIZATION OF HUMAN DUCTAL PROGENITOR CELLS AND THEIR REGENERATION POTENTIAL | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $230,250 | September 25, 2018 | June 30, 2023 | DOMINGUEZ-BENDALA, JUAN | reporter.nih.gov |
| Downregulation of 24-Dehydrocholesterol Reductase in Monocytes Improves Arteriogenesis in Peripheral Arterial Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $230,250 | December 1, 2023 | November 30, 2026 | LASSANCE-SOARES, ROBERTA MARQUES | reporter.nih.gov |
| Pharmaco-epidemiology of diabetes in patients with end-stage kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $230,250 | February 15, 2024 | November 30, 2026 | GALINDO, RODOLFO | reporter.nih.gov |
| University of Miami kidney Innovative & Interdisciplinary Medical Education in Research Activities (UM-KIIMERA) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $226,418 | August 1, 2020 | July 31, 2030 | FORNONI, ALESSIA | reporter.nih.gov |
| Core mechanisms that contribute to inhibition of wound healing in diabetic foot and venous leg ulcers | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $218,958 | June 1, 2022 | May 31, 2027 | BURGESS, JAMIE LEE | reporter.nih.gov |
| Addressing Disaster Displacement for Recovery with Equitable and Sustainable Systems (ADDRESS) of HIV Care in Puerto Rico | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $218,795 | September 16, 2024 | March 31, 2029 | CASANOVA, FELICIA | reporter.nih.gov |
| Neurotoxicity of Spermine Synthase-deficiency and Polyamine Imbalance | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $218,496 | September 14, 2023 | May 1, 2024 | ZHAI, RONG GRACE | reporter.nih.gov |
| Syndemics, the microbiome, and mucosal inflammation involved in HIV acquisition | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $210,690 | September 1, 2021 | August 31, 2024 | CHERENACK, EMILY MELLISSA | reporter.nih.gov |
| The Role of Oxidative Phosphorylation Complexes in Beta Cell Biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $209,964 | April 1, 2021 | March 31, 2024 | LANG, ANNA L | reporter.nih.gov |
| Overcoming Drug Resistance Driven by BCL10 Mutations in Diffuse Large B Cell Lymphoma | NIH | National Cancer Institute | 2021 to 2024 | $209,456 | August 1, 2021 | July 31, 2025 | COUGHLIN, CAROLINE ALICE | reporter.nih.gov |
| The BCI (Brain Computer Interface) Glaucoma Study: Objective Home-Based Detection of Progressive Visual Function Loss in Glaucoma | NIH | National Eye Institute | 2022 | $208,063 | March 1, 2019 | February 28, 2025 | MEDEIROS, FELIPE | reporter.nih.gov |
| Increasing early infant male circumcision uptake in Zambia: Like Father, Like Son | NIH | National Institute of Mental Health | 2021 | $197,891 | September 1, 2019 | June 30, 2023 | WEISS, STEPHEN M. | reporter.nih.gov |
| Determining Barriers Leading to Inferior Survival for Black and Hispanic Patients with Hodgkin Lymphoma: A Patient-Centered Study | NIH | National Cancer Institute | 2025 | $197,449 | February 1, 2025 | August 31, 2030 | MAILHOT, RAYMOND B | reporter.nih.gov |
| Mitochondrial mRNA structure as a driver of Leigh Syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $193,555 | January 1, 2022 | May 31, 2025 | MORAN, JOHN CONOR | reporter.nih.gov |
| Novel role of inflammasome activation in ART neurotoxicity | NIH | National Institute of Mental Health | 2021 | $191,875 | May 12, 2020 | February 29, 2024 | TOBOREK, MICHAL | reporter.nih.gov |
| Opioid Drug Ontology (ODO) | NIH | National Institute on Drug Abuse | 2021 | $191,875 | September 1, 2020 | August 31, 2023 | SCHURER, STEPHAN C | reporter.nih.gov |
| Elucidating Mechanisms of Mitochondrial Biogenesis in T Cell Immunity | NIH | National Cancer Institute | 2025 | $189,648 | April 1, 2025 | March 31, 2028 | KURMI, KIRAN | reporter.nih.gov |
| Uncovering an Enzymatic Program that Drives Physiological and Pathological Amyloid Formation. | NIH | National Institute on Aging | 2023 to 2024 | $186,811 | January 1, 2023 | December 31, 2024 | BOKROS, MICHAEL | reporter.nih.gov |
| Assessing Axonal Fate, Myelination and Visual Function Recovery after New Gene Treatment | NIH | National Eye Institute | 2021 | $186,118 | August 1, 2020 | July 31, 2023 | PARK, KEVIN KYUNG | reporter.nih.gov |
| Epigenetic Regulation of Retinal Development by BCOR | NIH | National Eye Institute | 2021 to 2024 | $185,643 | March 1, 2021 | May 31, 2024 | ZHANG, MICHELLE | reporter.nih.gov |
| The Effects of Low-Dose IL-2 Therapy on Beta Cell Dysfunction in Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $183,561 | April 1, 2021 | May 31, 2024 | QURESHI, FARHAN | reporter.nih.gov |
| Using natural language processing to determine predictors of healthy diet and physical activity behavior change in ovarian cancer survivors | NIH | National Cancer Institute | 2022 | $181,863 | February 1, 2022 | December 31, 2023 | CRANE, TRACY E | reporter.nih.gov |
| Role of pericytes in pancreatic islet fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $181,764 | January 1, 2017 | December 31, 2022 | ALMACA, JOANA | reporter.nih.gov |
| Targeting Wnt-dependent colorectal cancer | NIH | National Cancer Institute | 2021 | $166,963 | March 1, 2018 | May 31, 2021 | ROBBINS, DAVID J | reporter.nih.gov |
| Family-based eHealth Obesity Prevention Intervention for Hispanic Adolescents | NIH | National Heart, Lung, and Blood Institute | 2021 | $164,786 | August 19, 2016 | October 31, 2022 | ST. GEORGE, SARA MIJARES | reporter.nih.gov |
| Strategies to attenuate the indirect alloimmune response in encapsulated pancreatic islet transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $161,206 | April 1, 2023 | March 31, 2027 | LI, CHRIS MICHAEL | reporter.nih.gov |
| Hypertensive Disorders of Pregnancy – The Black/White Disparity | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $161,206 | April 1, 2023 | March 31, 2027 | DODDS, LEAH VERNA | reporter.nih.gov |
| Mechanisms of Neurodegeneration in CMT4B3: a Complex Pediatric Neurodevelopmental Disorder | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $161,206 | August 1, 2023 | July 31, 2027 | JACOBS, ELIZABETH HALEY | reporter.nih.gov |
| Machine Learning and Radiomics Techniques for Analysis of Daily MRI in Glioblastoma Patients | NIH | National Cancer Institute | 2023 to 2025 | $161,206 | September 1, 2023 | August 31, 2026 | CULLISON, KAYLIE | reporter.nih.gov |
| Elucidating the Understudied Kinase PNCK as a Prospective Drug Target in Renal Cell Carcinoma | NIH | National Center for Advancing Translational Sciences | 2023 | $159,381 | June 1, 2023 | May 31, 2024 | SCHURER, STEPHAN C | reporter.nih.gov |
| Prenatal Opioid Exposure and Inflammation: The Role of the Microbiome and Epigenome. | NIH | National Institute on Drug Abuse | 2022 to 2024 | $158,420 | June 1, 2022 | May 31, 2025 | ABU, YAA | reporter.nih.gov |
| Glomerulus on a Chip: A Model to Study Glomerular Hyperfiltration | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $158,420 | September 6, 2022 | April 28, 2025 | ALVER, CHARLES GARCIA | reporter.nih.gov |
| Regulation of esophageal tumorigenesis by protein adduction | NIH | National Cancer Institute | 2024 to 2025 | $153,500 | January 1, 2024 | December 31, 2026 | CASPA GOKULAN, RAVINDRAN | reporter.nih.gov |
| Mechanisms of regulatory T cell processes by IL-2 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $148,696 | September 1, 2021 | May 13, 2024 | SHOUSE, ACACIA NICOLE | reporter.nih.gov |
| Role and regulation of inflammasome in the intraocular pressure-induced injury of retinal ganglion cells | NIH | National Eye Institute | 2022 to 2024 | $143,420 | January 10, 2022 | January 31, 2025 | SPURLOCK, MARKUS | reporter.nih.gov |
| Ischemic Stroke in Cerebral Amyloid Angiopathy: Microvascular Injury and Recovery | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $143,420 | July 1, 2022 | June 30, 2025 | COLBERT, OLIVIA MARLOWE | reporter.nih.gov |
| Interdisciplinary Research Training in Otolaryngology | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2022 | $127,479 | July 1, 2018 | June 30, 2024 | LIU, XUE Z | reporter.nih.gov |
| Risk and resilience mechanisms underlying race disparities in ADRD: An examination of neighborhood resources, social networks, brain integrity, and cognition | NIH | National Institute on Aging | 2025 | $123,336 | September 1, 2021 | May 31, 2027 | SOL, KETLYNE | reporter.nih.gov |
| Elucidating epigenetic mechanisms of cellular cadmium toxicity | NIH | National Institute of Environmental Health Sciences | 2021 | $122,996 | August 1, 2022 | August 31, 2024 | LOMBARD, DAVID BENNER | reporter.nih.gov |
| Biostatistics Center for Lebers Hereditary Optic Neuropathy (LHON): Gene Therapy Clinical Trial | NIH | National Eye Institute | 2021 to 2022 | $118,672 | April 1, 2014 | March 31, 2024 | O'BRIEN, ROBERT CHARLES | reporter.nih.gov |
| Impact of Obstructive Sleep Apnea and HIV on Ventricular Repolarization Lability | NIH | National Heart, Lung, and Blood Institute | 2025 | $115,125 | February 1, 2025 | January 31, 2027 | HERRERA ALDANA, PHABIOLA MACARENA | reporter.nih.gov |
| The Role of Parabrachial CGRP Neurons in Opioid Reinforcement | NIH | National Institute on Drug Abuse | 2024 to 2025 | $108,512 | May 1, 2024 | April 30, 2028 | BYSTROM, LAUREN L | reporter.nih.gov |
| A novel immunotherapy for pancreatic cancer using micro-RNA-29a | NIH | National Cancer Institute | 2024 to 2025 | $108,512 | August 1, 2024 | July 31, 2028 | RAFIE, CHRISTINE ISABELLE | reporter.nih.gov |
| The Role of CARM1-Dependent Arginine Methylation of BRD4 in Hematopoiesis | NIH | National Cancer Institute | 2021 to 2023 | $108,499 | July 1, 2020 | June 30, 2024 | MOOKHTIAR, ADNAN KASIM | reporter.nih.gov |
| Enhancing Leadership Capacity to Mentor Scientists in Translational Behavioral AD-Related Research (K07) | NIH | National Institute on Aging | 2021 | $104,397 | April 15, 2017 | March 31, 2023 | JEAN-LOUIS, GIRARDIN | reporter.nih.gov |
| Novel Therapeutics Targeting CARM1 Overexpression in AML | NIH | National Cancer Institute | 2021 to 2022 | $102,788 | November 1, 2018 | October 31, 2022 | UMEANO, AFOMA CHINYELU | reporter.nih.gov |
| Crosstalk between lipid droplets and other organelles in podocytes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $100,000 | March 20, 2015 | April 30, 2024 | FORNONI, ALESSIA | reporter.nih.gov |
| Defining Novel Redox Stress Mechanisms to Inhibit KRAS-driven Pancreatic Ductal Adenocarcinoma | NIH | National Cancer Institute | 2024 to 2025 | $98,512 | September 1, 2024 | August 31, 2027 | MATEO-VICTORIANO, BEATRIZ | reporter.nih.gov |
| Retargeting cytotoxic T lymphocytes in HIV/SIV infection to kill infected cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $98,396 | August 1, 2019 | May 31, 2023 | ROSEN, BRANDON C | reporter.nih.gov |
| Investigating Resistance Mechanisms to Non-covalent Bruton's Tyrosine Kinase Inhibitors and Therapeutic Approaches to Overcome Resistance for Patients with B-Cell Malignancies | NIH | National Cancer Institute | 2022 to 2023 | $94,446 | September 9, 2022 | September 8, 2025 | MONTOYA, OLIVIA SKYE | reporter.nih.gov |
| INVESTIGATING THE EFFECTS OF MENOPAUSE-INDUCED EPIGENETIC MECHANISMS IN THE BRAIN | NIH | National Institute on Aging | 2022 to 2023 | $93,968 | July 1, 2022 | June 30, 2024 | DENNISON, JESSICA LEE | reporter.nih.gov |
| Racial disparities in breast cancer risk and gene expression-roles of genetics and lifestyle factors | NIH | National Cancer Institute | 2025 | $88,490 | September 23, 2025 | August 31, 2027 | PING, JIE | reporter.nih.gov |
| Air Pollution, Sleep-Disordered Breathing, and Biomarkers of Sudden Cardiac Death Risk in Resource-Limited Settings | NIH | National Heart, Lung, and Blood Institute | 2025 | $87,244 | September 30, 2025 | KARMALI, DIPAN NISHIKANT | reporter.nih.gov | |
| Mechanisms of inflammation in lipid-laden macrophages after spinal cord injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $84,004 | December 1, 2019 | July 31, 2022 | RYAN, CHRISTINE BETHANY | reporter.nih.gov |
| The contribution of the APOM/S1P signaling axis to podocyte injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $82,193 | May 16, 2024 | March 31, 2026 | TOLERICO, MATTHEW ROBERT | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 248 | $180,216,738 | 0 | $0 |
| 2024 | 269 | $167,261,096 | 0 | $0 |
| 2023 | 281 | $175,627,446 | 0 | $0 |
| 2022 | 262 | $177,888,263 | 1 | $20,000 |
| 2021 | 251 | $156,586,698 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Neurosciences
- Clinical Research
- Genetics
- Brain Disorders
- Prevention
- Cancer
- Behavioral and Social Science
- Rare Diseases
- Biotechnology
- Neurodegenerative
- Aging
- Infectious Diseases
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.